Scientia Professor Anthony Kelleher

Kelleher AD; Cooper DA, 2012, 'Chapter 6 Acute HIV infection', in Sande's HIV/AIDS Medicine, Elsevier, pp. 77 - 88, http://dx.doi.org/10.1016/b978-1-4557-0695-2.00006-7

Alford J; Kelleher AD, 2009, 'The immunosuppressed patient', in Fulde G (ed.), Emergency Medicine, the Principles of Practice, edn. 5th, Elsevier, Australia, pp. 665 - 686, http://shop.mja.com.au/

Kelleher A; Kelly M, 2009, 'Immune Restoration Diseases', in Hoy J; Lewin S; Post JJ; Street A (ed.), HIV Management in Australasia: a guide for clinical care, pp. 287 - 294

Alford J; Kelleher A, 2009, 'The immunosuppressed patient', in Emergency Medicine, Elsevier, pp. 665 - 686, http://dx.doi.org/10.1016/b978-0-7295-3876-3.10042-5

Ramacciotti TP; Kelleher AD; Cooper DA, 2008, 'Infeccion primaria por HIV. [Primary HIV-1 Infection]', in Benettuci JA (ed.), SIDA y Enfermedades Associadas (AIDS and Infectious Diseases), 3a edicion., edn. 3rd, FUNDAI, Buenos Aires, pp. 155 - 170

Kelleher AD; Cooper DA, 2008, 'Acute HIV Infection', in Volberding PA; Sande MA; Greene WC; Lange JMA (ed.), Global HIV/AIDS Medicine, Elsevier Inc, Philadelphia, PA, pp. 63 - 74, http://dx.doi.org/10.1016/B978-1-4160-2882-6.50010-1

Kelleher AD; Cooper DA, 2008, 'CHAPTER 6 Acute HIV Infection', in Global HIV/AIDS Medicine, Elsevier, pp. 63 - 74, http://dx.doi.org/10.1016/b978-1-4160-2882-6.50010-1

Ramacciotti TP; Smith DE; Emery S; Kelleher AD; Cooper DA, 2005, 'Therapeutic vaccination in PHI', in Jenssen H; Jager H (ed.), Primary HIV Infection ? Pathology, Diagnosis, Management, edn. Original, Thieme, Stuttgart, pp. 48 - 63

Stewart GJ; Irvine SS; Scott M; Kelleher A; Marriot D; McKnight I; Pethebridge AM; Wodak A; Ziegler J, 1997, 'Strategies in managing HIV', in Stewart GJ (ed.), Managing HIV

Kelleher A; Orth D, 1997, 'Early HIV-induced immune depletion', in Stewart GJ (ed.), Managing HIV, Medical Journal of Australia

Agbosu EE; Ledger S; Kelleher AD; Wen J; Ahlenstiel CL, 2022, 'Targeted Nanocarrier Delivery of RNA Therapeutics to Control HIV Infection', Pharmaceutics, vol. 14, pp. 1352 - 1352, http://dx.doi.org/10.3390/pharmaceutics14071352

Rankin K; Beaton B; Sasson S; Raedemaecker J; Wong A; Hastak P; Phetsouphanh C; Warden A; Patel M; Klemm V; Munier CML; Carey Hoppe A; Tea F; Pillay A; Ospina A; Aggarwal A; Lavee O; Caterson ID; Turville S; Kelleher AD; Brilot F; Trotman J, 2022, 'PB2087: EFFICACY OF A 3RD COVID VACCINE, INCLUDING DURING A BTKI PAUSE, IN INDIVIDUALS WITH WALDENSTRÖM MACROGLOBULINEMIA AND FOLLICULAR LYMPHOMA', HemaSphere, vol. 6, pp. 1958 - 1959, http://dx.doi.org/10.1097/01.hs9.0000851180.32970.18

Boyd MA; van Bockel D; Munier CML; Kelleher AD, 2022, 'Navigating the complexity of chronic HIV-1 associated immune dysregulation', Current Opinion in Immunology, vol. 76, pp. 102186, http://dx.doi.org/10.1016/j.coi.2022.102186

Aggarwal A; Stella AO; Walker G; Akerman A; Esneau C; Milogiannakis V; Burnett DL; McAllery S; Silva MR; Lu Y; Foster CSP; Brilot F; Pillay A; Van Hal S; Mathivanan V; Fichter C; Kindinger A; Hoppe AC; Munier ML; Amatayakul-Chantler S; Roth N; Coppola G; Symonds GP; Schofield P; Jackson J; Lenthall H; Henry JY; Mazigi O; Jäck HM; Davenport MP; Darley DR; Matthews GV; Khoury DS; Cromer D; Goodnow CC; Christ D; Robosa R; Starck DJ; Bartlett NW; Rawlinson WD; Kelleher AD; Turville SG, 2022, 'Platform for isolation and characterization of SARS-CoV-2 variants enables rapid characterization of Omicron in Australia', Nature Microbiology, vol. 7, pp. 896 - 908, http://dx.doi.org/10.1038/s41564-022-01135-7

Kelleher AD, 2022, 'Pacific Eclipse: Before the corona dawn', Vaccine, vol. 40, pp. 2474 - 2475, http://dx.doi.org/10.1016/j.vaccine.2021.02.021

Duette G; Hiener B; Morgan H; Mazur FG; Mathivanan V; Horsburgh BA; Fisher K; Tong O; Lee E; Ahn H; Shaik A; Fromentin R; Hoh R; Bacchus-Souffan C; Nasr N; Cunningham AL; Hunt PW; Chomont N; Turville SG; Deeks SG; Kelleher AD; Schlub TE; Palmer S, 2022, 'The HIV-1 proviral landscape reveals that Nef contributes to HIV-1 persistence in effector memory CD4⁺ T cells', Journal of Clinical Investigation, vol. 132, http://dx.doi.org/10.1172/JCI154422

Zhang Y; Almazi JG; Ong HX; Johansen MD; Ledger S; Traini D; Hansbro PM; Kelleher AD; Ahlenstiel CL, 2022, 'Nanoparticle Delivery Platforms for RNAi Therapeutics Targeting COVID-19 Disease in the Respiratory Tract', International Journal of Molecular Sciences, vol. 23, http://dx.doi.org/10.3390/ijms23052408

Fisher K; Wang XQ; Lee A; Morcilla V; De Vries A; Lee E; Eden JS; Deeks SG; Kelleher AD; Palmer S, 2022, 'Plasma-Derived HIV-1 Virions Contain Considerable Levels of Defective Genomes', Journal of Virology, vol. 96, pp. e0201121, http://dx.doi.org/10.1128/jvi.02011-21

Amodio A; Cassani M; Mummolo L; Cortez-Jugo C; Bhangu SK; Symons J; Ahlenstiel CL; Forte G; Ricci F; Kelleher AD; Lewin SR; Cavalieri F; Caruso F, 2022, 'Nanoscale probing and imaging of HIV-1 RNA in cells with a chimeric LNA-DNA sensor', Nanoscale, vol. 14, pp. 3049 - 3061, http://dx.doi.org/10.1039/d1nr08418f

Balachandran H; Phetsouphanh C; Agapiou D; Adhikari A; Rodrigo C; Hammoud M; Shrestha LB; Keoshkerian E; Gupta M; Turville S; Christ D; King C; Sasson SC; Bartlett A; Grubor-Bauk B; Rawlinson W; Aggarwal A; Stella AO; Klemm V; Mina MM; Post JJ; Hudson B; Gilroy N; Konecny P; Ahlenstiel G; Dwyer DE; Sorrell TC; Kelleher A; Tedla N; Lloyd AR; Martinello M; Bull RA, 2022, 'Maintenance of broad neutralizing antibodies and memory B cells 1 year post-infection is predicted by SARS-CoV-2-specific CD4+ T cell responses', Cell Reports, vol. 38, pp. 110345, http://dx.doi.org/10.1016/j.celrep.2022.110345

Phetsouphanh C; Darley DR; Wilson DB; Howe A; Munier CML; Patel SK; Juno JA; Burrell LM; Kent SJ; Dore GJ; Kelleher AD; Matthews GV, 2022, 'Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection', Nature Immunology, vol. 23, pp. 210 - 216, http://dx.doi.org/10.1038/s41590-021-01113-x

Law H; Mach M; Howe A; Obeid S; Milner B; Carey C; Elfis M; Fsadni B; Ognenovska K; Phan TG; Carey D; Xu Y; Venturi V; Zaunders J; Kelleher AD; Munier CML, 2022, 'Early expansion of CD38+ICOS+ GC Tfh in draining lymph nodes during influenza vaccination immune response', iScience, vol. 25, pp. 103656 - 103656, http://dx.doi.org/10.1016/j.isci.2021.103656

Aggarwal A; Stella A; Walker G; Akerman A; Milogiannakis V; Brilot F; Amatayakul-Chantler S; Roth N; Coppola G; Schofield P; Jackson J; Lenthall H; Mazigi O; Langley D; Lu Y; Forster C; McAllery S; Mathivanan V; Fitcher C; Hoppe AC; Munier CML; Jack H-M; Cromer D; Darley D; Matthews G; Christ D; Khoury D; Davenport M; Rawlinson W; Kelleher A; Turville S, 2022, 'SARS-CoV-2 Omicron: evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern', , http://dx.doi.org/10.21203/rs.3.rs-1207364/v1

Beaton B; Sasson SC; Rankin K; Raedemaeker J; Wong A; Hastak P; Phetsouphanh C; Warden A; Klemm V; Munier CML; Hoppe AC; Tea F; Pillay A; Stella AO; Aggarwal A; Lavee O; Caterson ID; Turville S; Kelleher AD; Brilot F; Trotman J, 2022, 'Patients with treated indolent lymphomas immunized with BNT162b2 have reduced anti-spike neutralizing IgG to SARS-CoV-2 variants, but preserved antigen-specific T cell responses', American Journal of Hematology, http://dx.doi.org/10.1002/ajh.26619

Loprete J; Katelaris CH; Evans L; Kane A; McMullan B; Wainstein B; Wong M; Post J; Suan D; Swaminathan S; Richardson R; Rogers J; Torda A; Campbell DE; Kelleher AD; Law M; Carr A; Tong WWY, 2022, 'Standardized testing and written communication improve patient understanding of beta-lactam allergy testing outcomes: A multicenter, prospective study', Journal of Allergy and Clinical Immunology: Global, vol. 1, pp. 99 - 105, http://dx.doi.org/10.1016/j.jacig.2022.05.003

Krishnan A; Ellenberger K; Chansavath P; Kelleher A; Matthews G; Darley D; Holloway C, 2022, 'Myocardial Fibrosis Occurs in Non-Hospitalised Patients With Chronic Symptoms After COVID-19', Heart, Lung and Circulation, vol. 31, pp. S169 - S170, http://dx.doi.org/10.1016/j.hlc.2022.06.267

Burnett DL; Jackson KJL; Langley DB; Aggrawal A; Stella AO; Johansen MD; Balachandran H; Lenthall H; Rouet R; Walker G; Saunders BM; Singh M; Li H; Henry JY; Jackson J; Stewart AG; Witthauer F; Spence MA; Hansbro NG; Jackson C; Schofield P; Milthorpe C; Martinello M; Schulz SR; Roth E; Kelleher A; Emery S; Britton WJ; Rawlinson WD; Karl R; Schäfer S; Winkler TH; Brink R; Bull RA; Hansbro PM; Jäck HM; Turville S; Christ D; Goodnow CC, 2021, 'Immunizations with diverse sarbecovirus receptor-binding domains elicit SARS-CoV-2 neutralizing antibodies against a conserved site of vulnerability', Immunity, vol. 54, pp. 2908 - 2921.e6, http://dx.doi.org/10.1016/j.immuni.2021.10.019

Pinto A; Carrera A; Salem H; Thapa K; Shaik A; Petoumenos K; Cunningham P; Garsia R; Dwyer D; Cooper DA; Kelleher A, 2021, 'Evolution of HIV-1 Surveillance Drug Resistance Mutations over 10 Years in New South Wales, Australia', AIDS Research and Human Retroviruses, vol. 37, pp. 897 - 902, http://dx.doi.org/10.1089/aid.2016.0301

Gray J; Prestage G; Jin F; Phanuphak N; Friedman RK; Fairley CK; Kelleher A; Templeton D; Zablotska-Manos I; Hoy J; McNulty A; Pell C; Grulich A; Bavinton B; Zablotska IB; Grinsztejn B; Cooper DA; Emery S; Wilson D; Koelsch KK; Triffitt K; Doong N; Baker D; Bloch M; Tee BK; Moore R; Roth N; Orth D; Pinto AN, 2021, 'Characteristics of Agreements to have Condomless Anal Intercourse in the Presence of an Undetectable Viral Load Among HIV Serodiscordant Male Couples in Australia, Brazil and Thailand', AIDS and Behavior, vol. 25, pp. 3944 - 3954, http://dx.doi.org/10.1007/s10461-021-03324-7

Counoupas C; Johansen MD; Stella AO; Nguyen DH; Ferguson AL; Aggarwal A; Bhattacharyya ND; Grey A; Hutchings O; Patel K; Siddiquee R; Stewart EL; Feng CG; Hansbro NG; Palendira U; Steain MC; Saunders BM; Low JKK; Mackay JP; Kelleher AD; Britton WJ; Turville SG; Hansbro PM; Triccas JA, 2021, 'A single dose, BCG-adjuvanted COVID-19 vaccine provides sterilising immunity against SARS-CoV-2 infection', npj Vaccines, vol. 6, http://dx.doi.org/10.1038/s41541-021-00406-4

Phetsouphanh C; Phalora P; Hackstein CP; Thornhill J; Munier ML; Meyerowitz J; Murray L; Vuuren CV; Goedhals D; Drexhage L; Moore R; Sattentau Q; Mak JYW; Fairlie DP; Fidler S; Kelleher A; Frater J; Klenerman P, 2021, 'Human MAIT cells respond to and suppress HIV-1', eLife, vol. 10, http://dx.doi.org/10.7554/eLife.50324

Beaton B; Sasson SC; Rankin K; Raedemaeker J; Wong A; Hastak P; Warden A; Stella AO; Aggarwal A; Caterson ID; Phetsouphanh C; Turville S; Kelleher AD; Brilot F; Trotman J, 2021, 'Efficacy of Vaccine BNT162b2 (Pfizer-BioNTech) in Individuals with Waldenstrom's Macroglobulinemia and Follicular Lymphoma in Australia', BLOOD, vol. 138, http://dx.doi.org/10.1182/blood-2021-149348

Mwasakifwa GE; Amin J; Kelleher A; Boyd MA, 2021, 'Inflammatory biomarkers and soft tissue changes among patients commencing second-line antiretroviral therapy after first-line virological failure', AIDS (London, England), vol. 35, pp. 2289 - 2298, http://dx.doi.org/10.1097/QAD.0000000000003014

Yap JY; Moens L; Lin MW; Kane A; Kelleher A; Toong C; Wu KHC; Sewell WA; Phan TG; Hollway GE; Enthoven K; Gray PE; Casas-Martin J; Wouters C; De Somer L; Hershfield M; Bucciol G; Delafontaine S; Ma CS; Tangye SG; Meyts I, 2021, 'Intrinsic Defects in B Cell Development and Differentiation, T Cell Exhaustion and Altered Unconventional T Cell Generation Characterize Human Adenosine Deaminase Type 2 Deficiency', Journal of Clinical Immunology, vol. 41, pp. 1915 - 1935, http://dx.doi.org/10.1007/s10875-021-01141-0

Darley DR; Dore GJ; Byrne AL; Plit ML; Brew BJ; Kelleher A; Matthews GV, 2021, 'Limited recovery from post-acute sequelae of sars-cov-2 at 8 months in a prospective cohort', ERJ Open Research, vol. 7, pp. 00384 - 2021, http://dx.doi.org/10.1183/23120541.00384-2021

Patel PG; Keen P; McManus H; Duck T; Callander D; Selvey C; Power C; Gray RT; Knight V; Asselin J; Read P; Johnson K; Bavinton BR; Bowden VJ; Grulich AE; Guy R; Prestage G; Zablotska I; Holden J; Cooper C; Price K; Holt M; de Wit J; Kaldor J; Kelleher A; Wilson D; Brotherton A; Cooper DA; Crooks L; Whittaker B; Madeddu D; Schmidt HM; Telfer B; Boyd M; McGill S; Pinto A; Nigro S; Gordon T; Feeney L; Cunningham P; Mao L; Gray J; O’Dwyer M; Clifton B, 2021, 'Increased targeted HIV testing and reduced undiagnosed HIV infections among gay and bisexual men', HIV Medicine, vol. 22, pp. 605 - 616, http://dx.doi.org/10.1111/hiv.13102

Parsons MS; Kristensen AB; Selva KJ; Lee WS; Amarasena T; Esterbauer R; Wheatley AK; Bavinton BR; Kelleher AD; Grulich AE; Khoury G; Juno JA; Kent SJ, 2021, 'Protective efficacy of the anti-HIV broadly neutralizing antibody PGT121 in the context of semen exposure', EBioMedicine, vol. 70, pp. 103518, http://dx.doi.org/10.1016/j.ebiom.2021.103518

Tea F; Stella AO; Aggarwal A; Darley DR; Pilli D; Vitale D; Merheb V; Lee FXZ; Cunningham P; Walker GJ; Fichter C; Brown DA; Rawlinson WD; Isaacs SR; Mathivanan V; Hoffmann M; Pöhlman S; Mazigi O; Christ D; Rockett RJ; Sintchenko V; Hoad VC; Irving DO; Dore GJ; Gosbell IB; Kelleher AD; Matthews GV; Brilot F; Turville SG, 2021, 'SARS-CoV-2 neutralizing antibodies: Longevity, breadth, and evasion by emerging viral variants', PLoS Medicine, vol. 18, http://dx.doi.org/10.1371/journal.pmed.1003656

Mak G; Zaunders JJ; Bailey M; Seddiki N; Rogers G; Leong L; Phan TG; Kelleher AD; Koelsch KK; Boyd MA; Danta M, 2021, 'Preservation of Gastrointestinal Mucosal Barrier Function and Microbiome in Patients With Controlled HIV Infection', Frontiers in Immunology, vol. 12, http://dx.doi.org/10.3389/fimmu.2021.688886

Frith K; Munier CML; Hastings L; Mowat D; Wilson M; Seddiki N; Macintosh R; Kelleher AD; Gray P; Zaunders JJ, 2021, 'The role of zeb2 in human cd8 t lymphocytes: Clinical and cellular immune profiling in mowat–wilson syndrome', International Journal of Molecular Sciences, vol. 22, pp. 5324 - 5324, http://dx.doi.org/10.3390/ijms22105324

Henry RT; Jiamsakul A; Law M; Losso M; Kamarulzaman A; Phanuphak P; Kumarasamy N; Foulkes S; Mohapi L; Nwizu C; Wood R; Kelleher A; Polizzotto M, 2021, 'Factors Associated with and Characteristic of HIV/ Tuberculosis Co-Infection: A Retrospective Analysis of SECOND-LINE Clinical Trial Participants', Journal of Acquired Immune Deficiency Syndromes, vol. 87, pp. 720 - 729, http://dx.doi.org/10.1097/QAI.0000000000002619

Abayasingam A; Balachandran H; Agapiou D; Hammoud M; Rodrigo C; Keoshkerian E; Li H; Brasher NA; Christ D; Rouet R; Burnet D; Grubor-Bauk B; Rawlinson W; Turville S; Aggarwal A; Stella AO; Fichter C; Brilot F; Mina M; Post JJ; Hudson B; Gilroy N; Dwyer D; Sasson SC; Tea F; Pilli D; Kelleher A; Tedla N; Lloyd AR; Martinello M; Bull RA, 2021, 'Long-term persistence of RBD⁺ memory B cells encoding neutralizing antibodies in SARS-CoV-2 infection', Cell Reports Medicine, vol. 2, pp. 100228, http://dx.doi.org/10.1016/j.xcrm.2021.100228

Murray DD; Zaunders J; Milliken ST; Mee Ling Munier C; Ford C; Orla Morrissey C; Visweswaran M; Avery S; Sasadeusz J; Kwan J; Desai S; Law M; Koelsch KK; Lewin SR; Moore J; Kelleher AD; Polizzotto MN, 2021, 'Altered Immune Reconstitution in Allogeneic Stem Cell Transplant Recipients with Human Immunodeficiency Virus (HIV)', Clinical Infectious Diseases, vol. 72, pp. 1141 - 1146, http://dx.doi.org/10.1093/cid/ciaa748

Kelleher AD, 2021, 'Acute treatment with monoclonal antibodies: Their design and their use', Microbiology Australia, vol. 42, pp. 39 - 43, http://dx.doi.org/10.1071/MA21011

Darley D; Matthews G; Dore G; Wilhelm K; Plit M; Stone E; Byrne A; Tonga K; Andresen D; Kelleher A; Cysique L; Cunningham P; Brew B, 2021, 'Persistent symptoms up to four months after community and hospital- managed SARS- CoV- 2 infection', Medical Journal of Australia, http://dx.doi.org/10.5694/mja2.50963

Mar Minn M; Aung NM; Kyaw DZ; Zaw TT; Chann PN; Khine HE; McLoughlin S; Kelleher AD; Tun NL; Oo TZC; Myint NPST; Law M; Mar Kyi M; Hanson J, 2021, 'The comparative ability of commonly used disease severity scores to predict death or a requirement for ICU care in patients hospitalised with possible sepsis in Yangon, Myanmar', International Journal of Infectious Diseases, vol. 104, pp. 543 - 550, http://dx.doi.org/10.1016/j.ijid.2021.01.047

Walker GJ; Naing Z; Stella AO; Yeang M; Caguicla J; Ramachandran V; Isaacs SR; Agapiou D; Bull RA; Stelzer-Braid S; Daly J; Gosbell IB; Hoad VC; Irving DO; Pink JM; Turville S; Kelleher AD; Rawlinson WD, 2021, 'Sars coronavirus-2 microneutralisation and commercial serological assays correlated closely for some but not all enzyme immunoassays', Viruses, vol. 13, pp. 247 - 247, http://dx.doi.org/10.3390/v13020247

Seddiki N; Zaunders J; Phetsouphanh C; Brezar V; Xu Y; McGuire HM; Bailey M; McBride K; Hey-Cunningham W; Munier CML; Cook L; Kent S; Lloyd A; Cameron B; De St Groth BF; Koelsch K; Danta M; Hocini H; Levy Y; Kelleher AD, 2021, 'CD73⁺ CD127^high long-term memory CD4 T cells are highly proliferative in response to recall antigens and are early targets in hiv-1 infection', International Journal of Molecular Sciences, vol. 22, pp. 1 - 28, http://dx.doi.org/10.3390/ijms22020912

Ubolyam S; Iampornsin T; Sophonphan J; Avihingsanon A; Suwanpimolkul G; Kawkitinarong K; Manosuthi W; Gatechompol S; Ananworanich J; Ruxrungtham K; Phanuphak P; Kelleher AD, 2021, 'Performance of a simple flow cytometric assay in diagnosing active tuberculosis', Tuberculosis, vol. 126, pp. 102017, http://dx.doi.org/10.1016/j.tube.2020.102017

Di Giallonardo F; Pinto AN; Keen P; Shaik A; Carrera A; Salem H; Selvey C; Nigro SJ; Fraser N; Price K; Holden J; Lee FJ; Dwyer DE; Bavinton BR; Geoghegan JL; Grulich AE; Kelleher AD; Guy R; Prestage G; Zablotska I; Duck T; Cooper C; Holt M; de Wit J; Kaldor J; Wilson D; Brotherton A; Cooper DA; Crooks L; Whittaker B; Callander D; Madeddu D; Schmidt HM; Telfer B; Boyd M; McGill S; Patel P; Power C; Gordon T; Feeney L; Bath K; Mackie B, 2021, 'Subtype-specific differences in transmission cluster dynamics of HIV-1 B and CRF01_AE in New South Wales, Australia', Journal of the International AIDS Society, vol. 24, pp. e25655, http://dx.doi.org/10.1002/jia2.25655

Rouet R; Mazigi O; Walker GJ; Langley DB; Sobti M; Schofield P; Lenthall H; Jackson J; Ubiparipovic S; Henry JY; Abayasingam A; Burnett D; Kelleher A; Brink R; Bull RA; Turville S; Stewart AG; Goodnow CC; Rawlinson WD; Christ D, 2021, 'Potent SARS-CoV-2 binding and neutralization through maturation of iconic SARS-CoV-1 antibodies', mAbs, vol. 13, pp. 1922134, http://dx.doi.org/10.1080/19420862.2021.1922134

Darley DR; Dore GJ; Byrne A; Plit M; Brew BJ; Kelleher A; Matthews GV, 2021, 'Limited recovery from post-acute sequelae of SARS-CoV-2 (PASC) at eight months in a prospective cohort', , http://dx.doi.org/10.1101/2021.03.29.21254211

Phetsouphanh C; Darley D; Wilson D; Howe A; Ling Munier M; Patel S; Juno J; Burrell L; Kent S; Dore G; Kelleher A; Matthews G, 2021, 'Immunological dysfunction persists for 8 months following initial mild-moderate SARS-CoV-2 infection', , http://dx.doi.org/10.1101/2021.06.01.21257759

Tea F; Stella AO; Aggarwal A; Darley DR; Pilli D; Vitale D; Merheb V; Lee FXZ; Cunningham P; Walker GJ; Brown DA; Rawlinson WD; Isaacs SR; Mathivanan V; Hoffman M; Pöhlmann S; Dwyer DE; Rockett R; Sintchenko V; Hoad VC; Irving DO; Dore GJ; Gosbell IB; Kelleher AD; Matthews GV; Brilot F; Turville SG, 2020, 'SARS-CoV-2 neutralizing antibodies; longevity, breadth, and evasion by emerging viral variants', , http://dx.doi.org/10.1101/2020.12.19.20248567

Walker G; Naing Z; Stella AO; Yeang M; Caguicla J; Ramachandran V; Isaacs S; Agapiou D; Bull R; Stelzer-Braid S; Daly J; Gosbell I; Hoad V; Irving D; Pink J; Turville S; Kelleher A; Rawlinson W, 2020, 'SARS Coronavirus-2 microneutralisation and commercial serological assays correlated closely for some but not all enzyme immunoassays', , http://dx.doi.org/10.1101/2020.12.07.20245696

Sasson SC; Zaunders JJ; Nahar K; Munier CML; Fairfax BP; Olsson-Brown A; Jolly C; Read SA; Ahlenstiel G; Palendira U; Scolyer RA; Carlino MS; Payne MJ; Cheung VTF; Gupta T; Klenerman P; Long GV; Brain O; Menzies AM; Kelleher AD, 2020, 'Mucosal-associated invariant T (MAIT) cells are activated in the gastrointestinal tissue of patients with combination ipilimumab and nivolumab therapy-related colitis in a pathology distinct from ulcerative colitis', Clinical and Experimental Immunology, vol. 202, pp. 335 - 352, http://dx.doi.org/10.1111/cei.13502

Di Giallonardo F; Pinto AN; Keen P; Shaik A; Carrera A; Salem H; Selvey C; Nigro SJ; Fraser N; Price K; Holden J; Lee FJ; Dwyer DE; Bavinton BR; Grulich AE; Kelleher AD, 2020, 'Increased hiv subtype diversity reflecting demographic changes in the hiv epidemic in new south wales, australia', Viruses, vol. 12, http://dx.doi.org/10.3390/v12121402

Li Z; Khanna M; Grimley SL; Ellenberg P; Gonelli CA; Lee WS; Amarasena TH; Kelleher AD; Purcell DFJ; Kent SJ; Ranasinghe C, 2020, 'Mucosal IL-4R antagonist HIV vaccination with SOSIP-gp140 booster can induce high-quality cytotoxic CD4⁺/CD8⁺ T cells and humoral responses in macaques', Scientific Reports, vol. 10, http://dx.doi.org/10.1038/s41598-020-79172-7

Law H; Venturi V; Kelleher A; Mee Ling Munier C, 2020, 'Tfh cells in health and immunity: Potential targets for systems biology approaches to vaccination', International Journal of Molecular Sciences, vol. 21, pp. 1 - 21, http://dx.doi.org/10.3390/ijms21228524

Van Bockel D; Munier CML; Turville S; Badman SG; Walker G; Stella AO; Aggarwal A; Yeang M; Condylios A; Kelleher AD; Applegate TL; Vallely A; Whiley D; Rawlinson W; Cunningham P; Kaldor J; Guy R, 2020, 'Evaluation of commercially available viral transport medium (VTM) for SARS-CoV-2 inactivation and use in point-of-care (POC) testing', Viruses, vol. 12, pp. 1208 - 1208, http://dx.doi.org/10.3390/v12111208

Kelleher AD; Cortez-Jugo C; Cavalieri F; Qu Y; Glanville AR; Caruso F; Symonds G; Ahlenstiel CL, 2020, 'RNAi therapeutics: an antiviral strategy for human infections', Current Opinion in Pharmacology, vol. 54, pp. 121 - 129, http://dx.doi.org/10.1016/j.coph.2020.09.011

Mwasakifwa GE; Amin J; White CP; Center JR; Kelleher A; Boyd MA, 2020, 'Early changes in bone turnover and inflammatory biomarkers and clinically significant bone mineral density loss over 48 weeks among HIV-infected patients with virological failure of a standard first-line antiretroviral therapy regimen in the SECOND-LINE study', HIV Medicine, vol. 21, pp. 492 - 504, http://dx.doi.org/10.1111/hiv.12882

Ahlenstiel CL; Symonds G; Kent SJ; Kelleher AD, 2020, 'Block and Lock HIV Cure Strategies to Control the Latent Reservoir', Frontiers in Cellular and Infection Microbiology, vol. 10, http://dx.doi.org/10.3389/fcimb.2020.00424

Wragg KM; Tan HX; Kristensen AB; Nguyen-Robertson CV; Kelleher AD; Parsons MS; Wheatley AK; Berzins SP; Pellicci DG; Kent SJ; Juno JA, 2020, 'High CD26 and Low CD94 Expression Identifies an IL-23 Responsive Vδ2⁺ T Cell Subset with a MAIT Cell-like Transcriptional Profile', Cell Reports, vol. 31, http://dx.doi.org/10.1016/j.celrep.2020.107773

Zaunders J; Mee Ling Munier C; McGuire HM; Law H; Howe A; Xu Y; De St Groth BF; Schofield P; Christ D; Milner B; Obeid S; Dyer WB; Saksena NK; Kelleher AD, 2020, 'Mapping the extent of heterogeneity of human CCR5R CD4R T cells in peripheral blood and lymph nodes', AIDS, vol. 34, pp. 833 - 848, http://dx.doi.org/10.1097/QAD.0000000000002503

Kelleher A; Breit S; Levy JA, 2020, 'Professor Ronald Penny IN MEMORIAM', AIDS, vol. 34, pp. 959 - 960, http://dx.doi.org/10.1097/QAD.0000000000002520

Singh M; Jackson KJL; Wang JJ; Schofield P; Field MA; Koppstein D; Peters TJ; Burnett DL; Rizzetto S; Nevoltris D; Masle-Farquhar E; Faulks ML; Russell A; Gokal D; Hanioka A; Horikawa K; Colella AD; Chataway TK; Blackburn J; Mercer TR; Langley DB; Goodall DM; Jefferis R; Gangadharan Komala M; Kelleher AD; Suan D; Rischmueller M; Christ D; Brink R; Luciani F; Gordon TP; Goodnow CC; Reed JH, 2020, 'Lymphoma Driver Mutations in the Pathogenic Evolution of an Iconic Human Autoantibody', Cell, vol. 180, pp. 878 - 894.e19, http://dx.doi.org/10.1016/j.cell.2020.01.029

Cook L; Munier CML; Seddiki N; Hardy MY; Anderson RP; Zaunders J; Tye-Din JA; Kelleher AD; van Bockel D, 2020, 'Circulating gluten-specific, but not CMV-specific, CD39⁺ regulatory T cells have an oligoclonal TCR repertoire', Clinical and Translational Immunology, vol. 9, http://dx.doi.org/10.1002/cti2.1096

Breit S; Ziegler J; Kelleher AD, 2020, 'Vale Ron Penny AO (1936-2019): pioneer of clinical immunology OBITUARY', CLINICAL & TRANSLATIONAL IMMUNOLOGY, vol. 9, http://dx.doi.org/10.1002/cti2.1119

Pilli D; Zou A; Dawes R; Lopez JA; Tea F; Liyanage G; Lee FXZ; Merheb V; Houston SD; Pillay A; Jones HF; Ramanathan S; Mohammad S; Kelleher AD; Alexander SI; Dale RC; Brilot F, 2020, 'Pro-inflammatory dopamine-2 receptor-specific T cells in paediatric movement and psychiatric disorders', Clinical and Translational Immunology, vol. 9, http://dx.doi.org/10.1002/cti2.1229

Rouet R; Mazigi O; Walker G; Langley D; Sobti M; Schofield P; Lenthall H; Jackson J; Ubiparipovic S; Henry J; Abayasingam A; Burnett D; Kelleher A; Brink R; Bull R; Turville S; Stewart A; Goodnow C; Rawlinson W; Christ D, 2020, 'Potent SARS-CoV-2 binding and neutralization through maturation of iconic SARS-CoV-1 antibodies', , http://dx.doi.org/10.1101/2020.12.14.422791

Khanna M; Jackson RJ; Alcantara S; Amarasena TH; Li Z; Kelleher AD; Kent SJ; Ranasinghe C, 2019, 'Mucosal and systemic SIV-specific cytotoxic CD4 ⁺ T cell hierarchy in protection following intranasal/intramuscular recombinant pox-viral vaccination of pigtail macaques', Scientific Reports, vol. 9, pp. 5661, http://dx.doi.org/10.1038/s41598-019-41506-5

Selva KJ; Bavinton BR; Grulich AE; Pazgier M; Kelleher AD; Kent SJ; Parsons MS, 2019, 'Impact of HIV-1 viremia or sexually transmitted infection on semen-derived anti-HIV-1 antibodies and the immunosuppressive capacity of seminal plasma', European Journal of Immunology, vol. 49, pp. 2255 - 2258, http://dx.doi.org/10.1002/eji.201848055

Vaccher SJ; Marzinke MA; Templeton DJ; Haire BG; Ryder N; McNulty A; Foster R; Grulich AE; Zablotska IB; Bloch M; Carr A; Cheung C; Gianacas C; Guy R; Holt M; Kaldor J; Mackie B; Mayer K; McAllister J; Murphy D; Ooi C; Pell C; Poynten IM; Prestage G; de Wit J; Wright E; Callander D; Cooper D; Crooks L; Duck T; Holden J; Keen P; Kelleher A; Mitchell J; Price K; Selvey C; Schmidt HM; Telfer B; Whittaker B; Wilson D, 2019, 'Predictors of Daily Adherence to HIV Pre-exposure Prophylaxis in Gay/Bisexual Men in the PRELUDE Demonstration Project', AIDS and Behavior, vol. 23, pp. 1287 - 1296, http://dx.doi.org/10.1007/s10461-018-2353-5

Di Giallonardo F; Pinto AN; Keen P; Shaik A; Carrera A; Salem H; Telfer B; Cooper C; Price K; Selvey C; Holden J; Bachmann N; Lee FJ; Dwyer DE; Duchêne S; Holmes EC; Grulich AE; Kelleher AD, 2019, 'Limited sustained local transmission of HIV-1 CRF01_AE in New South Wales, Australia', Viruses, vol. 11, http://dx.doi.org/10.3390/v11050482

Bavinton BR; Prestage GP; Jin F; Phanuphak N; Grinsztejn B; Fairley CK; Baker D; Hoy J; Templeton DJ; Tee BK; Kelleher A; Grulich AE, 2019, 'Strategies used by gay male HIV serodiscordant couples to reduce the risk of HIV transmission from anal intercourse in three countries', Journal of the International AIDS Society, vol. 22, pp. e25277, http://dx.doi.org/10.1002/jia2.25277

Zaunders J; Dyer WB; Churchill M; Munier CML; Cunningham PH; Suzuki K; McBride K; Hey-Nguyen W; Koelsch K; Wang B; Hiener B; Palmer S; Gorry PR; Bailey M; Xu Y; Danta M; Seddiki N; Cooper DA; Saksena NK; Sullivan JS; Riminton S; Learmont J; Kelleher AD, 2019, 'Possible clearance of transfusion-acquired nef/LTR-deleted attenuated HIV-1 infection by an elite controller with CCR5 Delta 32 heterozygous and HLA-B57 genotype', JOURNAL OF VIRUS ERADICATION, vol. 5, pp. 73 - 83, http://dx.doi.org/10.1016/s2055-6640(20)30056-x

Van Santen DK; Van Der Helm JJ; Touloumi G; Pantazis N; Muga R; Gunsenheimer-Bartmeyer B; Gill MJ; Sanders E; Kelleher A; Zangerle R; Porter K; Prins M; Geskus RB, 2019, 'Effect of incident hepatitis C infection on CD4 cell count and HIV RNA trajectories based on a multinational HIV seroconversion cohort', AIDS, vol. 33, pp. 327 - 337, http://dx.doi.org/10.1097/QAD.0000000000002040

Gossez M; Martin GE; Pace M; Ramjee G; Premraj A; Kaleebu P; Rees H; Inshaw J; Stöhr W; Meyerowitz J; Hopkins E; Jones M; Hurst J; Porter K; Babiker A; Fidler S; Frater J, 2019, 'Virological remission after antiretroviral therapy interruption in female African HIV seroconverters', AIDS, vol. 33, pp. 185 - 197, http://dx.doi.org/10.1097/QAD.0000000000002044

Hemelaar J; Elangovan R; Yun J; Dickson-Tetteh L; Fleminger I; Kirtley S; Williams B; Gouws-Williams E; Ghys PD; Abimiku AG; Agwale S; Archibald C; Avidor B; Barbás MG; Barre-Sinoussi F; Barugahare B; Belabbes EH; Bertagnolio S; Birx D; Bobkov AF; Brandful J; Bredell H; Brennan CA; Brooks J; Bruckova M; Buonaguro L; Buonaguro F; Buttò S; Buve A; Campbell M; Carr J; Carrera A; Carrillo MG; Celum C; Chaplin B; Charles M; Chatzidimitriou D; Chen Z; Chijiwa K; Cooper D; Cunningham P; Dagnra A; de Gascun CF; Del Amo J; Delgado E; Dietrich U; Dwyer D; Ellenberger D; Ensoli B; Essex M; Gao F; Fleury H; Fonjungo PN; Foulongne V; Gadkari DA; García F; Garsia R; Gershy-Damet GM; Glynn JR; Goodall R; Grossman Z; Lindenmeyer-Guimarães M; Hahn B; Hamers RL; Hamouda O; Handema R; He X; Herbeck J; Ho DD; Holguin A; Hosseinipour M; Hunt G; Ito M; Bel Hadj Kacem MA; Kahle E; Kaleebu PK; Kalish M; Kamarulzaman A; Kang C; Kanki P; Karamov E; Karasi JC; Kayitenkore K; Kelleher T; Kitayaporn D; Kostrikis LG; Kucherer C; Lara C; Leitner T; Liitsola K; Lingappa J; Linka M; Lorenzana de Rivera I; Lukashov V; Maayan S; Mayr L; McCutchan F; Meda N; Menu E; Mhalu F, 2019, 'Global and regional molecular epidemiology of HIV-1, 1990–2015: a systematic review, global survey, and trend analysis', The Lancet Infectious Diseases, vol. 19, pp. 143 - 155, http://dx.doi.org/10.1016/S1473-3099(18)30647-9

Cahn P; Madero JS; Arribas JR; Antinori A; Ortiz R; Clarke AE; Hung CC; Rockstroh JK; Girard PM; Sievers J; Man C; Currie A; Underwood M; Tenorio AR; Pappa K; Wynne B; Fettiplace A; Gartland M; Aboud M; Smith K; Cassetti L; David D; Figueras L; Losso M; Lopardo G; Lupo S; Porteiro N; Sánchez M; Bloch M; Cooper D; Finlayson R; Kelleher A; Koh K; Lewis D; McMahon J; Moore R; Roth N; Shields M; De Wit S; Florence E; Goffard JC; Demeester R; Lacor P; Vandercam B; Vandekerckhove L; Angel J; Baril JG; Conway B; De Pokomandy A; Szabo J; Walmsley S; Bouchaud O; Chidiac C; Delobel P; Goujard C; Katlama C; Molina JM; Pialoux G; Philibert P; Bogner J; Esser S; Krznaric I; Lehmann C; Spinner C; Stellbrink HJ; Stephan C; Stoehr A; Barchi E; Caramello P; Castelli F; Cattelan AM; D'Arminio Monforte A; Di Biagio A; Di Perri G; Gori A; Maggiolo F; Menzaghi B; Migliorino G; Mussini C; Penco G; Puoti M; Rizzardini G; Gulminetti R; Lazzarin A; Quirino T; Sighinolfi L; Viale P; Amaya Tapia G; Andrade Villanueva J; Granados Reyes ER; Perez Rios A; Santoscoy Gomez M; Den Hollander J; Rijnders B; Hidalgo JA; Hercilla Vasquez L; Illescas L; Olczak A; Mansinho K; Correia Pacheco PP, 2019, 'Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials', The Lancet, vol. 393, pp. 143 - 155, http://dx.doi.org/10.1016/S0140-6736(18)32462-0

Davenport MP; Khoury DS; Cromer D; Lewin SR; Kelleher AD; Kent SJ, 2019, 'Functional cure of HIV: the scale of the challenge', Nature Reviews Immunology, vol. 19, pp. 45 - 54, http://dx.doi.org/10.1038/s41577-018-0085-4

Hey-Nguyen WJ; Bailey M; Xu Y; Suzuki K; Van Bockel D; Finlayson R; Leigh Brown A; Carr A; Cooper DA; Kelleher AD; Koelsch KK; Zaunders JJ, 2019, 'HIV-1 DNA Is Maintained in Antigen-Specific CD4+ T Cell Subsets in Patients on Long-Term Antiretroviral Therapy Regardless of Recurrent Antigen Exposure', AIDS Research and Human Retroviruses, vol. 35, pp. 112 - 120, http://dx.doi.org/10.1089/aid.2018.0235

Juno JA; Wragg KM; Kristensen AB; Lee WS; Selva KJ; Van Der Sluis RM; Kelleher AD; Bavinton BR; Grulich AE; Lewin SR; Kent SJ; Parsons MS, 2019, 'Modulation of the CCR5 Receptor/Ligand Axis by Seminal Plasma and the Utility of in Vitro versus in Vivo Models', Journal of Virology, vol. 93, http://dx.doi.org/10.1128/JVI.00242-19

Phetsouphanh C; Aldridge D; Marchi E; Munier CML; Meyerowitz J; Murray L; Van Vuuren C; Goedhals D; Fidler S; Kelleher A; Klenerman P; Frater J, 2019, 'Maintenance of functional CD57+ cytolytic CD4+ T cells in HIV+ elite controllers', Frontiers in Immunology, vol. 10, http://dx.doi.org/10.3389/fimmu.2019.01844

Polizzotto M; Van Bockel D; Law C; Roberts J; Buckland G; Just S; Comben S; Hillman R; Gilson R; Pett S; Poynten M; Law M; Kelleher A; Emery S, 2019, 'Clearance of HPV Anal Premalignant Lesions and Modulation of Systemic Immune Responses to HPV Oncogenes with Low Dose Pomalidomide', Annals of Oncology, vol. 30, pp. xi35 - xi35, http://dx.doi.org/10.1093/annonc/mdz451.005

Sasson SC; Cheung VTF; Gupta T; Zaunders JJ; Nahar K; Munier CM-L; Olsson-Brown A; Ahlenstiel G; Palendira U; Scolyer RA; Carlino MS; Long GV; Menzies AM; Kelleher A; Payne M; Fairfax B; Middleton MR; Klenerman P; Brain O, 2019, 'Tissue-based activation of mucosal-associated invariant T (MAIT) cells in combination ipilimumab and nivolumab checkpoint inhibitor (CI) colitis', Annals of Oncology, vol. 30, pp. v530 - v530, http://dx.doi.org/10.1093/annonc/mdz253.128

Moran I; Nguyen A; Khoo WH; Butt D; Bourne K; Young C; Hermes JR; Biro M; Gracie G; Ma CS; Munier CML; Luciani F; Zaunders J; Parker A; Kelleher AD; Tangye SG; Croucher PI; Brink R; Read MN; Phan TG, 2018, 'Memory B cells are reactivated in subcapsular proliferative foci of lymph nodes', Nature Communications, vol. 9, http://dx.doi.org/10.1038/s41467-018-05772-7

Pinto AN; Grey P; Shaik A; Cooper DA; Kelleher AD; Petoumenos K, 2018, 'Early Treatment of Primary HIV Infection Is Associated with Decreased Mortality', AIDS Research and Human Retroviruses, vol. 34, pp. 936 - 941, http://dx.doi.org/10.1089/aid.2017.0284

Méndez C; Ledger S; Petoumenos K; Ahlenstiel C; Kelleher AD, 2018, 'RNA-induced epigenetic silencing inhibits HIV-1 reactivation from latency', Retrovirology, vol. 15, http://dx.doi.org/10.1186/s12977-018-0451-0

Kent SJ; Hough S; Kelleher AD; Law MG; Hutchinson J; Catalfarmo M; van Bockel D; Lane C; Baker JV; Emery S, 2018, 'Vorapaxar for HIV-associated inflammation and coagulopathy (ADVICE): a randomised, double-blind, placebo-controlled trial', The Lancet HIV, vol. 5, pp. e553 - e559, http://dx.doi.org/10.1016/S2352-3018(18)30214-5

Pinto AN; Hawke K; Castley A; Chibo D; Giallonardo FD; Cooper C; Sawleshwarkar S; Kelleher A; Dwyer DE, 2018, 'HIV-1 subtype diversity, transmitted drug resistance and phylogenetics in Australia', Future Virology, vol. 13, pp. 575 - 584, http://dx.doi.org/10.2217/fvl-2018-0031

Bavinton BR; Pinto AN; Phanuphak N; Grinsztejn B; Prestage GP; Zablotska-Manos IB; Jin F; Fairley CK; Moore RD; Roth N; Bloch M; Pell C; McNulty AM; Baker D; Hoy J; Tee BK; Templeton DJ; Cooper DA; Emery S; Kelleher A; Grulich AE; Bas A; Cooper DA; Wilson D; Koelsch KK; Triffitt K; Doong N; Baker D; Bloch M; Pell C; Hoy J; Orth D, 2018, 'Viral suppression and HIV transmission in serodiscordant male couples: an international, prospective, observational, cohort study', The Lancet HIV, vol. 5, pp. e438 - e447, http://dx.doi.org/10.1016/S2352-3018(18)30132-2

Kelleher AD; Bamford L; Draganic D; Kaldor J, 2018, 'Obituary: David Cooper, transformative clinician scientist', CURRENT OPINION IN HIV AND AIDS, vol. 13, pp. 289 - 290, http://dx.doi.org/10.1097/COH.0000000000000476

Worley MJ; Fei K; Lopez-Denman AJ; Kelleher AD; Kent SJ; Chung AW, 2018, 'Neutrophils mediate HIV-specific antibody-dependent phagocytosis and ADCC', Journal of Immunological Methods, vol. 457, pp. 41 - 52, http://dx.doi.org/10.1016/j.jim.2018.03.007

Turville S; Kelleher A, 2018, 'Obituary: Remembering Professor David Cooper', Retrovirology, vol. 15, pp. 40, http://dx.doi.org/10.1186/s12977-018-0418-1

Keen P; Gray RT; Telfer B; Guy R; Schmidt H; Whittaker B; Holden J; Holt M; Kelleher A; Wilson D; Callander D; Cooper DA; Prestage GP; Selvey C; Grulich A, 2018, 'The 2016 HIV diagnosis and care cascade in New South Wales, Australia: meeting the UNAIDS 90-90-90 targets', Journal of the International AIDS Society, vol. 21, pp. e25109 - e25109, http://dx.doi.org/10.1002/jia2.25109

MacIntyre CR; Costantino V; Chen X; Segelov E; Chughtai AA; Kelleher A; Kunasekaran M; Lane JM, 2018, 'Influence of population immunosuppression and past vaccination on smallpox reemergence', Emerging Infectious Diseases, vol. 24, pp. 646 - 653, http://dx.doi.org/10.3201/eid2404.171233

Pinto A; Di Giallonardo F; Keen P; Cooper C; Telfer B; Cooper D; Grulich A; Kelleher A, 2018, 'A10 Using the molecular epidemiology of HIV transmission in New South Wales to inform public health response: Assessing the representativeness of linked phylogenetic data', Virus Evolution, vol. 4, http://dx.doi.org/10.1093/ve/vey010.009

Stirrup OT; Copas AJ; Phillips AN; Gill MJ; Geskus RB; Touloumi G; Young J; Bucher HC; Babiker AG; Kelleher T; Cooper D; Grey P; Finlayson R; Bloch M; Ramacciotti T; Gelgor L; Smith D; Zangerle R; Gill J; Lutsar I; Chêne G; Dabis F; Thiebaut R; Costagliola D; Guiguet M; Vanhems P; Chaix ML; Ghosn J; Meyer L; Boufassa F; Hamouda O; Meixenberger K; Bannert N; Bartmeyer B; Antoniadou A; Chrysos G; Daikos GL; Pantazis N; Katsarou O; Rezza G; Dorrucci M; Monforte A; Luca A; Prins M; Geskus R; Helm J; Schuitemaker H; Sannes M; Brubakk O; Kran AM; Rosinska M; Muga R; Tor J; Olalla P; Cayla J; Moreno S; Monge S; Amo J; Romero J; Pérez-Hoyos S; Sönnerborg A; Bucher C; Günthard H; Scherrer A; Malyuta R; Murphy G; Porter K; Johnson A; Babiker A; Pillay D; Morrison C; Salata R; Mugerwa R; Chipato T; Price MA; Gilmour J; Kamali A; Karita E, 2018, 'Predictors of CD4 cell recovery following initiation of antiretroviral therapy among HIV-1 positive patients with well-estimated dates of seroconversion', HIV Medicine, vol. 19, pp. 184 - 194, http://dx.doi.org/10.1111/hiv.12567

Jamil MS; McManus H; Callander D; Prestage G; Ali H; O’Connor CC; Chen M; McNulty AM; Knight V; Duck T; Keen P; Gray J; Medland N; Hellard M; Lewis DA; Grulich AE; Kaldor JM; Fairley CK; Donovan B; Guy RJ; Marshall L; Wilson D; Dickson B; Kong M; Smith LW; Cooper D; Selvey C; Holden J; Crooks L; Cooper C; Price K; de Wit J; Kelleher A; Mitchell J; Schmidt HM; Telfer B; Whittaker B, 2018, 'Understanding the Targeting and Uptake of HIV Testing Among Gay and Bisexual Men Attending Sexual Health Clinics', AIDS and Behavior, vol. 22, pp. 513 - 521, http://dx.doi.org/10.1007/s10461-017-2012-2

Deenick EK; Morey A; Danta M; Emmett L; Fay K; Gracie G; Ma CS; Macintosh R; Smith SABC; Sasson SC; Sewell WA; Cowley M; Tangye SG; Kelleher AD; Phan TG, 2018, 'Reversible Suppression of Lymphoproliferation and Thrombocytopenia with Rapamycin in a Patient with Common Variable Immunodeficiency', Journal of Clinical Immunology, vol. 38, pp. 159 - 162, http://dx.doi.org/10.1007/s10875-018-0477-z

Pett SL; Amin J; Horban A; Andrade-Villanueva J; Losso M; Porteiro N; Madero JS; Belloso W; Tu E; Silk D; Kelleher A; Harrigan R; Clark A; Sugiura W; Wolff M; Gill J; Gatell J; Clarke A; Ruxrungtham K; Prazuck T; Kaiser R; Woolley I; Alberto Arnaiz J; Cooper D; Rockstroh JK; Mallon P; Emery S; Fisher M; Rockstroh J; Stellbrink J; Merlin K; Yeung J; Fsadni B; Marks K; Suzuki K; Rismanto N; Salomon H; Rubio AE; Chibo D; Birch C; Swenson L; Chan D; Berg T; Obermeier M; Schuelter E; Aragon SS; Luebke N; Coughlan S; Dean J; Iwatani Y; Teran GR; Avila S; Sirivichayakul S; Naphassanant M; Ubolyam S; Kaye S; Land S; Walker S; Haubrich R; DeJesus E; Berthon-Jones N; Espinosa N; Courtney-Vega K; Absar N; Haskelberg H; Robson R; Donaldson A; Guelman D; Gambardella L; Valdovinos M; Arnaiz J; Beleta H; Ramos N; Targa M; Späth B; Boesecke C; Engelhardt A; Perry N; Beckthold B; Drummond F; Lefevre E; Corr S; Grant C; Lupo S; Peroni L; Sanchez M; De Paz Sierra M; Viloria G; Parlante A; Bissio E; Luchetti P; Confalonieri V; Warley E; Vieni I; Vilas C; Zarate A; Mayer G; Elliot J; Hagenauer M; Kelley M, 2018, 'Week 96 results of the randomized, multicentre Maraviroc Switch (MARCH) study', HIV Medicine, vol. 19, pp. 65 - 71, http://dx.doi.org/10.1111/hiv.12532

Soodla P; Simmons R; Huik K; Pauskar M; Jõgeda EL; Rajasaar H; Kallaste E; Maimets M; Avi R; Murphy G; Porter K; Lutsar I; Del Amo J; Meyer L; Bucher HC; Chêne G; Hamouda O; Pillay D; Prins M; Rosinska M; Sabin C; Touloumi G; Olson A; Cartier A; Fradette L; Walker S; Babiker A; De Luca A; Fisher M; Muga R; Kelleher T; Cooper D; Grey P; Finlayson R; Bloch M; Ramacciotti T; Gelgor L; Smith D; Zangerle R; Gill J; Dabis F; Thiebaut R; Costagliola D; Guiguet M; Vanhems P; Chaix ML; Ghosn J; Boufassa F; Meixenberger K; Bannert N; Bartmeyer B; Antoniadou A; Chrysos G; Daikos GL; Pantazis N; Katsarou O; Rezza G; Dorrucci M; Monforte ADA; Geskus R; van der Helm J; Schuitemaker H; Sannes M; Brubakk O; Kran AMB; Tor J; de Olalla PG; Cayla J; Moreno S; Monge S; del Romero J; Pérez-Hoyos S; Sönnerborg A; Günthard H; Scherrer A; Malyuta R; Johnson A; Phillips A; Morrison C; Price MA; Giaquinto C; Grarup J; Kirk O; Bailey H; Volny Anne A; Panteleev A; Thorne C; Aboulker JP; Albert J; Asandi S; De Wit S; Reiss P; Gatell J; Karpov I; Ledergerber B; Møller C; Rakhmanova A; Rockstroh J, 2018, 'HIV incidence in the Estonian population in 2013 determined using the HIV-1 limiting antigen avidity assay', HIV Medicine, vol. 19, pp. 33 - 41, http://dx.doi.org/10.1111/hiv.12535

Philpot SP; Prestage G; Ellard J; Grulich AE; Bavinton BR, 2018, 'How do gay serodiscordant couples in Sydney, Australia negotiate undetectable viral load for HIV prevention?', AIDS and Behavior, vol. 22, pp. 3981 - 3990, http://dx.doi.org/10.1007/s10461-018-2247-6

Tsukamoto T; Kariya R; Marks K; Hattori S; Ahlenstiel C; Symonds G; Okada S; Kelleher AD, 2018, 'Erratum: Transcriptional gene silencing limits CXCR4-associated depletion of bone marrow CD34R cells in HIV-1 infection (AIDS (2018) (2018) 32 (1737–1747) DOI: 10.1097/QAD.0000000000001882)', AIDS, vol. 32, pp. 2857 - 2858, http://dx.doi.org/10.1097/01.aids.0000547984.16868.93

Cook L; Munier CML; Seddiki N; van Bockel D; Ontiveros N; Hardy MY; Gillies JK; Levings MK; Reid HH; Petersen J; Rossjohn J; Anderson RP; Zaunders JJ; Tye-Din JA; Kelleher AD, 2017, 'Circulating gluten-specific FOXP3⁺CD39⁺ regulatory T cells have impaired suppressive function in patients with celiac disease', Journal of Allergy and Clinical Immunology, vol. 140, pp. 1592 - 1603.e8, http://dx.doi.org/10.1016/j.jaci.2017.02.015

Murray DD; Suzuki K; Law M; Trebicka J; Neuhaus Nordwall J; Johnson M; Vjecha MJ; Kelleher AD; Emery S, 2017, 'Circulating MIR-122 and MIR-200a as biomarkers for fatal liver disease in ART-treated, HIV-1-infected individuals', Scientific Reports, vol. 7, http://dx.doi.org/10.1038/s41598-017-11405-8

McLaren PJ; Pulit SL; Gurdasani D; Bartha I; Shea PR; Pomilla C; Gupta N; Gkrania-Klotsas E; Young EH; Bannert N; Del Amo J; Gill MJ; Gilmour J; Kellam P; Kelleher AD; Sönnerborg A; Zangerle R; Post FA; Fisher M; Haas DW; Walker BD; Porter K; Goldstein DB; Sandhu MS; De Bakker PIW; Fellay J, 2017, 'Evaluating the impact of functional genetic variation on HIV-1 Control', Journal of Infectious Diseases, vol. 216, pp. 1063 - 1069, http://dx.doi.org/10.1093/infdis/jix470

Nasr N; Alshehri AA; Wright TK; Shahid M; Heiner BM; Harman AN; Botting RA; Helbig KJ; Beard MR; Suzuki K; Kelleher AD; Hertzog P; Cunningham AL, 2017, 'Mechanism of interferon-stimulated gene induction in HIV-1- infected macrophages', Journal of Virology, vol. 91, http://dx.doi.org/10.1128/JVI.00744-17

Murray JM; Zaunders J; Emery S; Cooper DA; Hey-Nguyen WJ; Koelsch KK; Kelleher AD, 2017, 'HIV dynamics linked to memory CD4+ T cell homeostasis', PLoS ONE, vol. 12, http://dx.doi.org/10.1371/journal.pone.0186101

Smoleń-Dzirba J; Rosińska M; Janiec J; Beniowski M; Cycoń M; Bratosiewicz-Wąsik J; Wasik TJ; Kelleher T; Cooper D; Grey P; Finlayson R; Bloch M; Ramacciotti T; Gelgor L; Smith D; Zangerle R; Gill J; Lutsar I; Chêne G; Dabis F; Thiebaut R; Masquelier B; Costagliola D; Guiguet M; Vanhems P; Chaix ML; Ghosn J; Meyer L; Boufassa F; Hamouda O; Kücherer C; Bartmeyer B; Antoniadou A; Chrysos G; Daikos GL; Touloumi G; Pantazis N; Katsarou O; Rezza G; Dorrucci M; Monforte AD; De Luca A; Prins M; Geskus R; van der Helm J; Schuitemaker H; Sannes M; Brubakk O; Kran AMB; Muga R; Tor J; de Olalla PG; Cayla J; del Amo J; Moreno S; Monge S; del Romero J; Pérez-Hoyos S; Bucher HC; Rickenbach M; Francioli P; Malyuta R; Murphy G; Sabin C; Porter K; Johnson A; Phillips A; Babiker A; Pillay D; Morrison C; Salata R; Mugerwa R; Chipato T; Amornkul PN; Gilmour J; Kamali A; Karita E; Burns F; Giaquinto C; Gibb D; Grarup J; Kirk O; Kjaer J; Panteleev A; Reiss P; Thorne C; Aboulker JP; Albert J; Asandi S; De Wit S; De Wolf F; Gatell J; Karpov I; Ledergerber B; Lundgren J; Møller C; Rakhmanova A; Rockstroh J; Anne AV, 2017, 'HIV-1 infection in persons homozygous for CCR5-Δ32 allele: The next case and the review', AIDS Reviews, vol. 19, pp. 219 - 230

Madhavi V; Wines BD; Amin J; Emery S; Lopez E; Kelleher A; Center RJ; Mark Hogarth P; Chung AW; Kent SJ; Stratov I, 2017, 'HIV-1 Env- and Vpu-specific antibody-dependent cellular cytotoxicity responses associated with elite control of HIV', Journal of Virology, vol. 91, http://dx.doi.org/10.1128/JVI.00700-17

Phetsouphanh C; Xu Y; Munier ML; Zaunders JJ; Kelleher AD, 2017, 'Single-cell profiling of lineage determining transcription factors in antigen-specific CD4⁺ T cells reveals unexpected complexity in recall responses during immune reconstitution', Immunology and Cell Biology, vol. 95, pp. 640 - 646, http://dx.doi.org/10.1038/icb.2017.28

Koelsch KK; Rasmussen TA; Hey-Nguyen WJ; Pearson C; Xu Y; Bailey M; Marks KH; Sasson SC; Taylor MS; Tantau R; Obeid S; Milner B; Morrissey O; Pinto AN; Suzuki K; Busch MP; Keating SM; Kaiser P; Yukl S; Wong JK; Hiener BM; Palmer S; Zaunders J; Post JJ; Chan DJ; Avery S; Milliken ST; Kelleher AD; Lewin SR; Cooper DA, 2017, 'Impact of Allogeneic Hematopoietic Stem Cell Transplantation on the HIV Reservoir and Immune Response in 3 HIV-Infected Individuals', Journal of Acquired Immune Deficiency Syndromes, vol. 75, pp. 328 - 337, http://dx.doi.org/10.1097/QAI.0000000000001381

Madhavi V; Kulkarni A; Shete A; Lee WS; McLean MR; Kristensen AB; Ghate M; Wines BD; Hogarth PM; Parsons MS; Kelleher A; Cooper DA; Amin J; Emery S; Thakar M; Kent SJ, 2017, 'Effect of Combination Antiretroviral Therapy on HIV-1-specific Antibody-Dependent Cellular Cytotoxicity Responses in Subtype B- and Subtype C-Infected Cohorts', Journal of Acquired Immune Deficiency Syndromes, vol. 75, pp. 345 - 353, http://dx.doi.org/10.1097/QAI.0000000000001380

Hey-Nguyen WJ; Xu Y; Pearson CF; Bailey M; Suzuki K; Tantau R; Obeid S; Milner B; Field A; Carr A; Bloch M; Cooper DA; Kelleher AD; Zaunders JJ; Koelsch KK, 2017, 'Quantification of Residual Germinal Center Activity and HIV-1 DNA and RNA Levels Using Fine Needle Biopsies of Lymph Nodes during Antiretroviral Therapy', AIDS Research and Human Retroviruses, vol. 33, pp. 648 - 657, http://dx.doi.org/10.1089/aid.2016.0171

Zaunders J; Xu Y; Kent SJ; Koelsch KK; Kelleher AD, 2017, 'Divergent expression of CXCR5 and CCR5 on CD4⁺ T cells and the paradoxical accumulation of T follicular helper cells during HIV infection', Frontiers in Immunology, vol. 8, http://dx.doi.org/10.3389/fimmu.2017.00495

Kent SJ; Kelleher AD, 2017, 'Expanding role for type i Interferons in restricting HIV growth', Immunology and Cell Biology, vol. 95, pp. 417 - 418, http://dx.doi.org/10.1038/icb.2017.15

Castley A; Sawleshwarkar S; Varma R; Herring B; Thapa K; Dwyer D; Chibo D; Nguyen N; Hawke K; Ratcliff R; Garsia R; Kelleher A; Nolan D, 2017, 'A national study of the molecular epidemiology of HIV-1 in', PLoS ONE, vol. 12, http://dx.doi.org/10.1371/journal.pone.0170601

Xu Y; Phetsouphanh C; Suzuki K; Aggrawal A; Graff-Dubois S; Roche M; Bailey M; Alcantara S; Cashin K; Sivasubramaniam R; Koelsch KK; Autran B; Harvey R; Gorry PR; Moris A; Cooper DA; Turville S; Kent SJ; Kelleher AD; Zaunders J, 2017, 'HIV-1 and SIV predominantly use CCR5 expressed on a precursor population to establish infection in T follicular helper cells', Frontiers in Immunology, vol. 8, http://dx.doi.org/10.3389/fimmu.2017.00376

Murray JM; Maher S; Mota T; Suzuki K; Kelleher AD; Center RJ; Purcell D, 2017, 'Differentiating founder and chronic HIV envelope sequences', PLoS ONE, vol. 12, http://dx.doi.org/10.1371/journal.pone.0171572

Juno JA; Bockel DV; Kent SJ; Kelleher AD; Zaunders JJ; Munier CML, 2017, 'Cytotoxic CD4 T cells-friend or foe during viral infection?', Frontiers in Immunology, vol. 8, http://dx.doi.org/10.3389/fimmu.2017.00019

Zaunders J; Howe A; Ledger S; Kelleher A; Murray J; Symonds G, 2017, '23 Knockdown of CCR5 expression in antigen-specific cytotoxic CD4 T cells', Journal of Virus Eradication, vol. 3, pp. 14 - 15, http://dx.doi.org/10.1016/s2055-6640(20)30728-7

Klemm V; Mitchell J; Cortez-Jugo C; Cavalieri F; Symonds G; Caruso F; Kelleher AD; Ahlenstiel C, 2016, 'Achieving HIV-1 control through RNA-directed gene regulation', Genes, vol. 7, http://dx.doi.org/10.3390/genes7120119

Keoshkerian E; Hunter M; Cameron B; Nguyen N; Sugden P; Bull R; Zekry A; Maher L; Seddiki N; Zaunders J; Kelleher A; Lloyd AR; Dolan K; Haber P; Rawlinson W; Treloar C; Dore G; Luciani F, 2016, 'Hepatitis C-specific effector and regulatory CD4 T-cell responses are associated with the outcomes of primary infection', Journal of Viral Hepatitis, vol. 23, pp. 985 - 993, http://dx.doi.org/10.1111/jvh.12576

Tjiam MC; Sariputra L; Armitage JD; Taylor JPA; Kelleher AD; Tan DBA; Lee S; Fernandez S; French MA, 2016, 'Control of early HIV-1 infection associates with plasmacytoid dendritic cell-reactive opsonophagocytic IgG antibodies to HIV-1 p24', AIDS, vol. 30, pp. 2757 - 2765, http://dx.doi.org/10.1097/QAD.0000000000001242

Zaunders J; Danta M; Bailey M; Mak G; Marks K; Seddiki N; Xu Y; Templeton DJ; Cooper DA; Boyd MA; Kelleher AD; Koelsch KK, 2016, 'CD4⁺ T follicular helper and IgA⁺ B cell numbers in gut biopsies from HIV-infected subjects on antiretroviral therapy are similar to HIV-uninfected individuals', Frontiers in Immunology, vol. 7, http://dx.doi.org/10.3389/fimmu.2016.00438

Munier CML; van Bockel D; Bailey M; Ip S; Xu Y; Alcantara S; Liu SM; Denyer G; Kaplan W; Suzuki K; Croft N; Purcell A; Tscharke D; Cooper DA; Kent SJ; Zaunders JJ; Kelleher AD, 2016, 'The primary immune response to Vaccinia virus vaccination includes cells with a distinct cytotoxic effector CD4 T-cell phenotype', Vaccine, vol. 34, pp. 5251 - 5261, http://dx.doi.org/10.1016/j.vaccine.2016.09.009

Cook L; Zaunders JJ; Kelleher AD, 2016, 'Comment on "A cytokine- independent approach to identify antigen-specific human germinal center T follicular helper cells and rare antigen-specific CD41 T cells in blood', Journal of Immunology, vol. 197, pp. 2557 - 2558, http://dx.doi.org/10.4049/jimmunol.1601311

Mak G; Zaunders JJ; Bailey M; Seddiki N; Xu Y; Cooper D; Boyd M; Kelleher A; Danta M; Koelsch KK, 2016, 'Gut integrity, CD4+T follicular helper cells, and IgA plus B cells in gastrointestinal-associated lymphoid tissue following ART', JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, vol. 31, pp. 6 - 6, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000384664700008&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Pinkevych M; Cromer D; Tolstrup M; Grimm AJ; Cooper DA; Lewin SR; Søgaard OS; Rasmussen TA; Kent SJ; Kelleher AD; Davenport MP, 2016, 'Erratum: HIV Reactivation from Latency after Treatment Interruption Occurs on Average Every 5-8 Days-Implications for HIV Remission (PLoS Pathogens (2015) 11:7 (e1005000) DOI: 10.1371/journal.ppat.1005000)', PLoS Pathogens, vol. 12, pp. e1005745, http://dx.doi.org/10.1371/journal.ppat.1005745

Pinkevych M; Kent SJ; Tolstrup M; Lewin SR; Cooper DA; Søgaard OS; Rasmussen TA; Kelleher AD; Cromer D; Davenport MP, 2016, 'Modeling of Experimental Data Supports HIV Reactivation from Latency after Treatment Interruption on Average Once Every 5–8 Days', PLoS Pathogens, vol. 12, http://dx.doi.org/10.1371/journal.ppat.1005740

Pett SL; Amin J; Horban A; Andrade-Villanueva J; Losso M; Porteiro N; Madero JS; Belloso W; Tu E; Silk D; Kelleher A; Harrigan R; Clark A; Sugiura W; Wolff M; Gill J; Gatell J; Fisher M; Clarke A; Ruxrungtham K; Prazuck T; Kaiser R; Woolley I; Arnaiz JA; Cooper D; Rockstroh JK; Mallon P; Emery S, 2016, 'Maraviroc, as a switch option, in HIV-1-infected individuals with stable, well-controlled HIV replication and R5-tropic virus on their first Nucleoside/Nucleotide reverse transcriptase inhibitor plus ritonavir-boosted protease inhibitor regimen: Week 48 Results of the randomized, multicenter March study', Clinical Infectious Diseases, vol. 63, pp. 122 - 132, http://dx.doi.org/10.1093/cid/ciw207

Li J; Hardy K; Phetsouphanh C; Tu WJ; Sutcliffe EL; McCuaig R; Sutton CR; Zafar A; Mee Ling Munier C; Zaunders JJ; Xu Y; Theodoratos A; Tan A; SiewLim P; Knaute T; Masch A; Zerweck J; Brezar V; Milburn PJ; Dunn J; Casarotto MG; Turner SJ; Seddiki N; Kelleher AD; Rao S, 2016, 'Nuclear PKC-θ facilitates rapid transcriptional responses in human memory CD4⁺T cells through p65 and H2B phosphorylation', Journal of Cell Science, vol. 129, pp. 2448 - 2461, http://dx.doi.org/10.1242/jcs.181248

Pantazis N; Touloumi G; Meyer L; Olson A; Costagliola D; Kelleher AD; Lutsar I; Chaix ML; Fisher M; Moreno S; Porter K, 2016, 'The impact of transient combination antiretroviral treatment in early HIV infection on viral suppression and immunologic response in later treatment', AIDS, vol. 30, pp. 879 - 888, http://dx.doi.org/10.1097/QAD.0000000000000991

McAllery SA; Ahlenstiel CL; Suzuki K; Symonds GP; Kelleher AD; Turville SG, 2016, 'The feasibility of incorporating Vpx into lentiviral gene therapy vectors', Molecular Therapy - Methods and Clinical Development, vol. 3, pp. 16066, http://dx.doi.org/10.1038/mtm.2016.66

Appay V; Kelleher AD, 2016, 'Immune activation and immune aging in HIV infection', Current Opinion in HIV and AIDS, vol. 11, pp. 242 - 249, http://dx.doi.org/10.1097/COH.0000000000000240

Zaunders J; Jing J; Leipold M; Maecker H; Kelleher AD; Koch I, 2016, 'Computationally efficient multidimensional analysis of complex flow cytometry data using second order polynomial histograms', Cytometry Part A, vol. 89, pp. 44 - 58, http://dx.doi.org/10.1002/cyto.a.22704

2016, 'Oral abstracts of the 21st International AIDS Conference 18-22 July 2016, Durban, South Africa.', J Int AIDS Soc, vol. 19, pp. 21264, http://dx.doi.org/10.7448/IAS.19.6.21264

Pantazis N; Touloumi G; Meyer L; Olson A; Costagliola D; Kelleher AD; Lutsar I; Chaix ML; Fisher M; Moreno S; Porter K, 2015, 'The impact of transient cART in early HIV infection on viral suppression and immunologic response in later treatment', AIDS, http://dx.doi.org/10.1097/QAD.0000000000000991

Jarrin I; Pantazis N; Dalmau J; Phillips AN; Olson A; Mussini C; Boufassa F; Costagliola D; Porter K; Blanco J; Del Amo J; Martinez-Picado J; Chene G; Sabin C; Walker S; Fisher M; Kelleher T; Cooper D; Finlayson R; Bloch M; Ramacciotti T; Gelgor L; Smith D; Zangerle R; Gill J; Lutsar I; Dabis F; Thiebaut R; Guiguet M; Vanhems P; Chaix ML; Ghosn J; Meyer L; Hamouda O; Kucherer C; Bartmeyer B; Antoniadou A; Chrysos G; Daikos GL; Touloumi G; Katsarou O; Rezza G; Dorrucci M; Monforte ADA; De Luca A; Prins M; Geskus R; Van Der Helm J; Schuitemaker H; Sannes M; Brubakk O; Kran AMB; Rosinska M; Muga R; Tor J; De Olalla PG; Cayla J; Moreno S; Monge S; Del Romero J; Perez-Hoyos S; Sonnerborg A; Bucher HC; Gunthard H; Rickenbach M; Malyuta R; Murphy G; Johnson A; Babiker A; Pillay D; Morrison C; Salata R; Mugerwa R; Chipato T; Amornkul PN; Gilmour J; Kamali A; Karita E; Burns F; Giaquinto C; Grarup J; Kirk O; Bailey H; Anne AV; Panteleev A; Thorne C; Aboulker JP; Albert J; Asandi S; De Wit S; Reiss P; Gatell J; Karpov I; Ledergerber B; Lundgren J; Møller C; Rakhmanova A; Rockstroh J; Sandhu M; Dedes N, 2015, 'Does rapid HIV disease progression prior to combination antiretroviral therapy hinder optimal CD4 + T-cell recovery once HIV-1 suppression is achieved?', AIDS, vol. 29, pp. 2323 - 2333, http://dx.doi.org/10.1097/QAD.0000000000000805

Murray DD; Suzuki K; Law M; Trebicka J; Neuhaus J; Wentworth D; Johnson M; Vjecha MJ; Kelleher AD; Emery S; Aagaard B; Aragon E; Arnaiz J; Borup L; Clotet B; Dragsted U; Fau A; Gey D; Grarup J; Hengge U; Herrero P; Jansson P; Jensen B; Jensen K; Juncher H; Lopez P; Lundgren JD; Matthews C; Mollerup D; Pearson M; Phillips A; Reilev S; Tillmann K; Varea S; Angus B; Babiker A; Cordwell B; Darbyshire J; Dodds W; Fleck S; Horton J; Hudson F; Moraes Y; Pacciarini F; Palfreeman A; Paton N; Smith N; Van Hooff F; Bebchuk J; Collins G; Denning E; DuChene A; Fosdick L; Harrison M; Herman-Lamin K; Krum E; Larson G; Neaton J; Nelson R; Quan K; Quan S; Schultz T; Thompson G; Wyman N; Carey C; Chan F; Cooper D; Courtney-Rodgers D; Drummond F; Harrod M; Jacoby S; Kearney L; Lin E; Pett S; Robson R; Seneviratne N; Stewart M; Watts E; Finley E; Gordin F; Sánchez A; Standridge B; Belloso W; Davey R; Duprez D; Gatell J; Hoy J; Lifson A; Pederson C; Perez G; Price R; Prineas R; Rhame F; Sampson J; Worley J; Modlin J; Beral V; Chaisson R; Fleming T; Hill C, 2015, 'Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection: A case control study', PLoS ONE, vol. 10, http://dx.doi.org/10.1371/journal.pone.0139981

Hurst J; Hoffmann M; Pace M; Williams JP; Thornhill J; Hamlyn E; Meyerowitz J; Willberg C; Koelsch KK; Robinson N; Brown H; Fisher M; Kinloch S; Cooper DA; Schechter M; Tambussi G; Fidler S; Babiker A; Weber J; Kelleher AD; Phillips RE; Frater J, 2015, 'Immunological biomarkers predict HIV-1 viral rebound after treatment interruption', Nature Communications, vol. 6, http://dx.doi.org/10.1038/ncomms9495

Sasson SC; McGill K; Wienholt L; Carr A; Brown DA; Kelleher AD; Breit SN; Sewell WA, 2015, 'Comparison of the Freelite serum free light chain (SFLC) assay with serum and urine electrophoresis/immunofixation and the N Latex FLC assay', Pathology, vol. 47, pp. 564 - 569, http://dx.doi.org/10.1097/PAT.0000000000000316

Ahlenstiel C; Mendez C; Lim STH; Marks K; Turville S; Cooper DA; Kelleher AD; Suzuki K, 2015, 'Novel RNA duplex locks HIV-1 in a latent state via chromatin-mediated transcriptional silencing', Molecular Therapy - Nucleic Acids, vol. 4, pp. e261, http://dx.doi.org/10.1038/mtna.2015.31

Lundgren JD; Babiker AG; Gordin F; Emery S; Grund B; Sharma S; Avihingsanon A; Cooper DA; Fätkenheuer G; Llibre JM; Molina JM; Munderi P; Schechter M; Wood R; Klingman KL; Collins S; Clifford Lane H; Phillips AN; Neaton JD, 2015, 'Initiation of antiretroviral therapy in early asymptomatic HIV infection', New England Journal of Medicine, vol. 373, pp. 795 - 807, http://dx.doi.org/10.1056/NEJMoa1506816

Phetsouphanh C; Zaunders JJ; Kelleher AD, 2015, 'Detecting antigen-specific T cell responses: From bulk populations to single cells', International Journal of Molecular Sciences, vol. 16, pp. 18878 - 18893, http://dx.doi.org/10.3390/ijms160818878

Méndez C; Ahlenstiel CL; Kelleher AD, 2015, 'Post-transcriptional gene silencing, transcriptional gene silencing and human immunodeficiency virus.', World J Virol, vol. 4, pp. 219 - 244, http://dx.doi.org/10.5501/wjv.v4.i3.219

Hoehn KB; Gall A; Bashford-Rogers R; Fidler SJ; Kaye S; Weber JN; McClure MO; Kellam P; Pybus OG; Breckenridge A; Clayden P; Conlon C; Conradie F; Kaldor J; Maggiolo F; Ssali F; Cooper DA; Kaleebu P; Ramjee G; Schechter M; Tambussi G; Weber J; Fidler S; Babiker A; Peto T; McLaren A; Beral V; Chene G; Hakim J; Porter K; Thomason M; Ewings F; Gabriel M; Johnson D; Thompson K; Cursley A; Donegan K; Fossey E; Kelleher P; Lee K; Murphy B; Nock D; Phillips R; Frater J; Ohm Laursen L; Robinson N; Goulder P; Brown H; McClure M; Bonsall D; Erlwein O; Helander A; Robinson M; Cook L; Adcock G; Ahmed P; Paton N; Kelleher A; Moore R; McFarlane R; Roth N; Finlayson R; Tee BK; Read T; Kelly M; Doong N; Bloch M; Workman C; Grey P; Cooper DA; Lawr M; Schechter M; Gama P; Mercon M; Barbosa de Souza M; Beppu Yoshida C; Grangeiro da Silva JR; Sampaio Amaral A; Fernandes de Aguiar D; de Fátima Melo M; Quaresma Garrido R; Tambussi G; Nozza S; Pogliaghi M; Chiappetta S; Della Torre L; Gasparotto E; D'Offizi G; Vlassi C; Corpolongo A; Wood R; Pitt J; Orrell C; Cilliers F; Croxford R, 2015, 'Dynamics of immunoglobulin sequence diversity in HIV-1 infected individuals', Philosophical Transactions of the Royal Society B: Biological Sciences, vol. 370, http://dx.doi.org/10.1098/rstb.2014.0241

Pinkevych M; Cromer D; Tolstrup M; Grimm AJ; Cooper DA; Lewin SR; Søgaard OS; Rasmussen TA; Kent SJ; Kelleher AD; Davenport MP, 2015, 'HIV Reactivation from Latency after Treatment Interruption Occurs on Average Every 5-8 Days—Implications for HIV Remission', PLoS Pathogens, vol. 11, http://dx.doi.org/10.1371/journal.ppat.1005000

Amin J; Becker S; Belloso W; Boffito M; Cooper D; Crabtree-Ramirez B; Duncombe C; Foulkes S; Hill A; Jessen H; Kumar S; Lee MP; Nwizu C; Read T; Rooney J; Schaffer K; Shahar E; Winston A; Wolff M; Young B; Abela C; Avihingsanon A; Boyd M; Carey D; Clarke A; Courtney-Vega K; Delfino M; Donaldson A; Emery S; Espinosa N; Johannesen T; Lin E; Losso M; Moricz A; Pett S; Phanupak P; Puls R; Pussadee K; Sutheerasak P; Tomlins L; Ubolyam S; bin Raja Azwa RIS; Bissio E; Calanni L; Chetchotisakd P; Doong N; Elliott J; Gazzard B; Kelly M; Laplume H; del Carmen Luna N; Lupo S; Messina OG; Mohapi L; Moore R; Nolan D; Orrell C; Perez C; Phanuphak P; Rockstroh J; Rowling D; Supparatpinyo K; Smith D; Villanueva JA; Vlahakis E; Kelleher T; Cunningham P; Merlin K; Yeung J; Shaik A; Fsadni B; Carrera A; Lograsso M; Gulick R; Dunn D; Dolan M, 2015, 'Efficacy and safety of efavirenz 400 mg daily versus 600 mg daily: 96-week data from the randomised, double-blind, placebo-controlled, non-inferiority ENCORE1 study', The Lancet Infectious Diseases, vol. 15, pp. 793 - 802, http://dx.doi.org/10.1016/S1473-3099(15)70060-5

Hey-Cunningham WJ; Murray JM; Natarajan V; Amin J; Moore CL; Emery S; Cooper DA; Zaunders J; Kelleher AD; Koelsch KK; PINT study team , 2015, 'Early antiretroviral therapy with raltegravir generates sustained reductions in HIV reservoirs but not lower T-cell activation levels.', AIDS, vol. 29, pp. 911 - 919, http://dx.doi.org/10.1097/QAD.0000000000000625

Suan D; Nguyen A; Moran I; Bourne K; Hermes JR; Arshi M; Hampton HR; Tomura M; Miwa Y; Kelleher AD; Kaplan W; Deenick EK; Tangye SG; Brink R; Chtanova T; Phan TG, 2015, 'T Follicular Helper Cells Have Distinct Modes of Migration and Molecular Signatures in Naive and Memory Immune Responses', Immunity, vol. 42, pp. 704 - 718, http://dx.doi.org/10.1016/j.immuni.2015.03.002

Winston A; Amin J; Clarke A; Else L; Amara A; Owen A; Barber T; Jessen H; Avinghsanon A; Chetchotisakd P; Khoo S; Cooper DA; Emery S; Puls R, 2015, 'Cerebrospinal fluid exposure of efavirenz and its major metabolites when dosed at 400 mg and 600 mg once daily: A randomized controlled trial', Clinical Infectious Diseases, vol. 60, pp. 1026 - 1032, http://dx.doi.org/10.1093/cid/ciu976

Madhavi V; Ana-Sosa-Batiz FE; Jegaskanda S; Center RJ; Winnall WR; Parsons MS; Ananworanich J; Cooper DA; Kelleher AD; Hsu D; Pett S; Stratov I; Kramski M; Kent SJ, 2015, 'Antibody-dependent effector functions against HIV decline in subjects receiving antiretroviral therapy', Journal of Infectious Diseases, vol. 211, pp. 529 - 538, http://dx.doi.org/10.1093/infdis/jiu486

Fernandez CS; Amarasena T; Kelleher AD; Rossjohn J; Mccluskey J; Godfrey DI; Kent SJ, 2015, 'MAIT cells are depleted early but retain functional cytokine expression in HIV infection', Immunology and Cell Biology, vol. 93, pp. 177 - 188, http://dx.doi.org/10.1038/icb.2014.91

Tong WWY; Shepherd K; Garland S; Meagher A; Templeton DJ; Fairley CK; Jin F; Poynten IM; Zaunders J; Hillman RJ; Grulich AE; Kelleher AD; Carr A; Acraman B; Fraissard E; Law C; McGrath P; Mellor R; Norris R; O'Dwyer M; Seeds D; Thompson K; Varma R; Adams M; Biro C; Cornall A; Crampton L; Ekman D; Ellard J; Farnsworth A; Feeney L; Howard K; Hyne S; Law M; Machalek D; McCaffery K; McDonald R; Pendlebury S; Petoumenos K; Phillips S; Prestage G; Richards A; Roberts J; Schema L; Segelov E; Tabrizi S; Thurloe J; Bailey M; Cunningham P; Fsadni B; Grassi K; Ip S; Lograsso M; McBride K; Merlin K; Munier M-L; Piperias M; Xu Y, 2015, 'Human Papillomavirus 16-Specific T-Cell Responses and Spontaneous Regression of Anal High-Grade Squamous Intraepithelial Lesions', Journal of Infectious Diseases, vol. 211, pp. 405 - 415, http://dx.doi.org/10.1093/infdis/jiu461

Boyd MA; Moore CL; Molina JM; Wood R; Madero JS; Wolff M; Ruxrungtham K; Losso M; Renjifo B; Teppler H; Kelleher AD; Amin J; Emery S; Cooper DA, 2015, 'Baseline HIV-1 resistance, virological outcomes, and emergent resistance in the SECOND-LINE trial: An exploratory analysis', The Lancet HIV, vol. 2, pp. e42 - e51, http://dx.doi.org/10.1016/S2352-3018(14)00061-7

Suzuki K; Ahlenstiel C; Marks K; Kelleher AD, 2015, 'Promoter targeting RNAs: Unexpected contributors to the control of HIV-1 transcription', Molecular Therapy - Nucleic Acids, vol. 4, http://dx.doi.org/10.1038/mtna.2014.67

Zaunders J; Jing J; Leipold M; Maecker H; Kelleher AD; Koch I, 2015, 'Computationally efficient multidimensional analysis of complex flow cytometry data using second order polynomial histograms', Cytometry Part A, http://dx.doi.org/10.1002/cyto.a.22704

Phetsouphanh C; Kelleher AD, 2015, 'The role of PKC-θ in CD4+ T cells and HIV infection: To the nucleus and back again', Frontiers in Immunology, vol. 6, http://dx.doi.org/10.3389/fimmu.2015.00391

Ahlenstiel CL; Suzuki K; Marks K; Symonds GP; Kelleher AD, 2015, 'Controlling HIV-1: Non-coding RNA gene therapy approaches to a functional cure', Frontiers in Immunology, vol. 6, http://dx.doi.org/10.3389/fimmu.2015.00474

Colineau L; Rouers A; Yamamoto T; Xu Y; Urrutia A; Pham HP; Cardinaud S; Samri A; Dorgham K; Coulon PG; Cheynier R; Hosmalin A; Oksenhendler E; Six A; Kelleher AD; Zaunders J; Koup RA; Autran B; Moris A; Graff-Dubois S, 2015, 'HIV-infected spleens present altered follicular helper T cell (Tfh) subsets and skewed B cell maturation', PLoS ONE, vol. 10, http://dx.doi.org/10.1371/journal.pone.0140978

Tong WWY; Turville S; Roberts J; Zaunders J; Jin F; Poynten IM; Hillman RJ; Grulich AE; Kelleher AD; Carr A, 2015, 'P10.10 T-cells in the anal mucosa of men with high-grade squamous intraepithelial lesions', Sexually Transmitted Infections, vol. 91, pp. A168.2 - A168, http://dx.doi.org/10.1136/sextrans-2015-052270.438

Sasson SC; McGill K; Wienholt L; Carr A; Brown D; Kelleher AD; Breit SN; Sewell WA, 2015, 'Retrospective audit of the freeliteTM serum free light chain (SFLC) assay: testing patterns, concordance with serum and urine electrophoresis/immunofixation and correlation with the N latex FLC assay', Pathology, vol. 47, pp. S94 - S94, http://dx.doi.org/10.1097/01.pat.0000461601.28805.d5

Koelsch KK; Hey-Cunningham WJ; Sasson SC; Pearson C; Bailey M; Marks KH; Hiener BM; Palmer S; Zaunders JJ; Post JJ; Milliken ST; Kelleher AD; Cooper DA; Xu Y, 2015, 'Allogeneic bone marrow transplantation in two HIV-1 infected patients shows no detectable HIV-1 RNA or DNA, and a profound reduction in HIV-1 antibodies', Pathology, vol. 47, pp. S55 - S55, http://dx.doi.org/10.1097/01.pat.0000461459.26902.eb

Bavinton BR; Jin F; Prestage G; Zablotska I; Koelsch KK; Phanuphak N; Grinsztejn B; Cooper DA; Fairley C; Kelleher A; Triffitt K; Grulich AE, 2014, 'The Opposites Attract Study of viral load, HIV treatment and HIV transmission in serodiscordant homosexual male couples: Design and methods', BMC Public Health, vol. 14, http://dx.doi.org/10.1186/1471-2458-14-917

Sasson S; Smith S; Sewell WA; Morey A; Danta M; Emmett L; Kelleher AD; Fay K; Phan T, 2014, 'MONOCLONAL B-CELL POPULATION OF INDETERMINANT MALIGNANT POTENTIAL IN THE SETTING OF ATYPICAL CVID ASSOCIATED WITH LYMPHADENOPATHY AND SPLENOMEGALY', INTERNAL MEDICINE JOURNAL, vol. 44, pp. 33 - 33, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000342722800109&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Martin E; Carlson JM; Le AQ; Chopera DR; McGovern R; Rahman MA; Ng C; Jessen H; Kelleher AD; Markowitz M; Allen TM; Milloy MJ; Carrington M; Wainberg MA; Brumme ZL, 2014, 'Early immune adaptation in HIV-1 revealed by population-level approaches', Retrovirology, vol. 11, http://dx.doi.org/10.1186/s12977-014-0064-1

Sasson SC; Kelleher AD, 2014, 'Site-specific host gene modification by zinc finger nucleases: pointing the way to drug free control of HIV-1?', Clinical and Translational Immunology, vol. 3, http://dx.doi.org/10.1038/cti.2014.12

Achhra AC; Boyd MA; Law MG; Matthews GV; Kelleher AD; Cooper DA, 2014, 'Moving away from ritonavir, abacavir, tenofovir, and efavirenz (RATE) - Agents that concern prescribers and patients: A feasibility study and call for a trial', PLoS ONE, vol. 9, http://dx.doi.org/10.1371/journal.pone.0099530

Kelleher AD, 2014, 'Promoter targeted small RNAs: stabilising viral reservoirs', MICROBIOLOGY AUSTRALIA, vol. 35, pp. 103 - 104, http://dx.doi.org/10.1071/MA14033

Haskelberg H; Cordery DV; Amin J; Kelleher AD; Cooper DA; Emery S, 2014, 'HLA Alleles association with changes in bone mineral density in HIV-1-infected adults changing treatment to tenofovir-emtricitabine or abacavir-lamivudine', PLoS ONE, vol. 9, http://dx.doi.org/10.1371/journal.pone.0093333

Tong WWY; Hillman RJ; Kelleher AD; Grulich AE; Carr A, 2014, 'Anal intraepithelial neoplasia and squamous cell carcinoma in HIV-infected adults', HIV Medicine, vol. 15, pp. 65 - 76, http://dx.doi.org/10.1111/hiv.12080

Hsu DC; Kerr SJ; Thongpaeng P; Iampornsin T; Pett SL; Zaunders JJ; Avihingsanon A; Ubolyam S; Ananworanich J; Kelleher AD; Cooper DA, 2014, 'Incomplete restoration of Mycobacterium tuberculosis-specific-CD4 T cell responses despite antiretroviral therapy', Journal of Infection, vol. 68, pp. 344 - 354, http://dx.doi.org/10.1016/j.jinf.2013.11.016

Phetsouphanh C; Xu Y; Bailey M; Pett S; Zaunders J; Seddiki N; Kelleher AD, 2014, 'Ratios of effector to central memory antigen-specific CD4 + T cells vary with antigen exposure in HIV+ patients', Immunology and Cell Biology, vol. 92, pp. 384 - 388, http://dx.doi.org/10.1038/icb.2013.101

Murray JM; Zaunders JJ; McBride KL; Xu Y; Bailey M; Suzuki K; Cooper DA; Emery S; Kelleher AD; Koelsch KK, 2014, 'HIV DNA subspecies persist in both activated and resting memory CD4⁺ T cells during antiretroviral therapy', Journal of Virology, vol. 88, pp. 3516 - 3526, http://dx.doi.org/10.1128/JVI.03331-13

Amin J; Becker S; Belloso W; Boffito M; Cooper D; Crabtree-Ramirez B; Duncombe C; Emery S; Foulkes S; Hill A; Jessen H; Kumar S; Lee MP; Losso M; Nwizu C; Phanuphak P; Ripin D; Read T; Rooney J; Schaffer K; Shahar E; Winston A; Wolff M; Young B; Abela C; Boyd M; Carey D; Clarke A; Courtney-Vega K; Dazo C; Delfino M; Donaldson A; Espinosa N; Johannesen T; Kaew-On P; Lin E; Moricz A; Taylor J; Phanupak P; Puls RL; Pussadee K; Sutheerasak P; Tomkins L; Ubolyam S; Shah Bin Raja Azwa RI; Bissio E; Calanni L; Casiro A; Chetchotisakd P; Contarelli J; Doong N; Elliott J; Gazzard B; Kelly M; Del Carmen Luna N; Lupo S; Messina OG; Mohapi L; Moore R; Nolan D; Orrell C; Perez C; Pett S; Rockstroh J; Supparatpinyo K; Smith D; Villanueva JA; Vlahakis E; Kelleher T; Cunningham P; Merlin K; Yeung J; Shaik A; Fsadni B; Carrera A; Lograsso M; Gulick R; Crabtree-Ramiraz B; Winston E; Dunn D; Dolan M, 2014, 'Efficacy of 400 mg efavirenz versus standard 600 mg dose in HIV-infected, antiretroviral-naive adults (ENCORE1): A randomised, double-blind, placebo-controlled, non-inferiority trial', The Lancet, vol. 383, pp. 1474 - 1482, http://dx.doi.org/10.1016/S0140-6736(13)62187-X

Seddiki N; Cook L; Hsu DC; Phetsouphanh C; Brown K; Xu Y; Kerr SJ; Cooper DA; Munier CML; Pett S; Ananworanich J; Zaunders J; Kelleher AD, 2014, 'Human antigen-specific CD4⁺CD25⁺CD134⁺CD39⁺ T cells are enriched for regulatory T cells and comprise a substantial proportion of recall responses', European Journal of Immunology, vol. 44, pp. 1644 - 1661, http://dx.doi.org/10.1002/eji.201344102

Fernandez CS; Kelleher AD; Finlayson R; Godfrey DI; Kent SJ, 2014, 'NKT cell depletion in humans during early HIV infection', Immunology and Cell Biology, vol. 92, pp. 578 - 590, http://dx.doi.org/10.1038/icb.2014.25

Swaminathan S; Kelleher AD, 2014, 'MicroRNA modulation of key targets associated with T cell exhaustion in HIV-1 infection', Current Opinion in HIV and AIDS, vol. 9, pp. 464 - 471, http://dx.doi.org/10.1097/COH.0000000000000089

Streeck H; Lu R; Beckwith N; Milazzo M; Liu M; Routy JP; Little S; Jessen H; Kelleher AD; Hecht F; Sekaly RP; Alter G; Heckerman D; Carrington M; Rosenberg ES; Altfeldc M, 2014, 'Emergence of individual HIV-specific CD8 T cell responses during primary HIV-1 infection can determine long-term disease outcome', Journal of Virology, vol. 88, pp. 12793 - 12801, http://dx.doi.org/10.1128/JVI.02016-14

Amin J; Law MG; Puls R; Kelleher A; Cooper DA; Emery S, 2014, 'Comparison of central and local HIV-1 RNA quantification from two international clinical trials', AIDS, vol. 28, pp. 2480 - 2483, http://dx.doi.org/10.1097/QAD.0000000000000461

Pantazis N; Porter K; Costagliola D; De Luca A; Ghosn J; Guiguet M; Johnson AM; Kelleher AD; Morrison C; Thiebaut R; Wittkop L; Touloumi G, 2014, 'Temporal trends in prognostic markers of HIV-1 virulence and transmissibility: An observational cohort study', The Lancet HIV, vol. 1, pp. e119 - e126, http://dx.doi.org/10.1016/S2352-3018(14)00002-2

Ana-Sosa-Batiz F; Johnston APR; Liu H; Center RJ; Rerks-Ngarm S; Pitisuttithum P; Nitayaphan S; Kaewkungwal J; Kim JH; Michael NL; Kelleher AD; Stratov I; Kent SJ; Kramski M, 2014, 'HIV-specific antibody-dependent phagocytosis matures during HIV infection', Immunology and Cell Biology, vol. 92, pp. 679 - 687, http://dx.doi.org/10.1038/icb.2014.42

Pham QD; Wilson DP; Law MG; Kelleher AD; Zhang L, 2014, 'Global burden of transmitted HIV drug resistance and HIV-exposure categories: A systematic review and meta-analysis', AIDS, vol. 28, pp. 2751 - 2762, http://dx.doi.org/10.1097/QAD.0000000000000494

Kuang XT; Li X; Anmole G; Mwimanzi P; Shahid A; Le AQ; Chong L; Qian H; Miura T; Markle T; Baraki B; Connick E; Daar ES; Jessen H; Kelleher AD; Little S; Markowitz M; Pereyra F; Rosenberg ES; Walker BD; Ueno T; Brumme ZL; Brockman MA, 2014, 'Impaired Nef function is associated with early control of HIV-1 viremia', Journal of Virology, vol. 88, pp. 10200 - 10213, http://dx.doi.org/10.1128/JVI.01334-14

Williams JP; Hurst J; Stöhr W; Robinson N; Brown H; Fisher M; Kinloch S; Cooper D; Schechter M; Tambussi G; Fidler S; Carrington M; Babiker A; Weber J; Koelsch KK; Kelleher AD; Phillips RE; Frater J, 2014, 'HIV-1 DNA predicts disease progression and post-treatment virological control', eLife, vol. 3, pp. e03821, http://dx.doi.org/10.7554/eLife.03821

Kelleher AD, 2014, 'Promoter targeted small RNAs: stabilising viral reservoirs', Microbiology Australia, vol. 10, pp. 1071

Murray JM; Zaunders JJ; Koelsch KK; Natarajan V; Badralmaa Y; McBride K; Carrera A; Cooper DA; Emery S; Kelleher AD, 2013, 'Short communication: HIV blips while on antiretroviral therapy can indicate consistently detectable viral levels due to assay underreporting', AIDS Research and Human Retroviruses, vol. 29, pp. 1621 - 1625, http://dx.doi.org/10.1089/aid.2013.0132

Vaidya SA; Streeck H; Beckwith N; Ghebremichael M; Pereyra F; Kwon DS; Addo MM; Rychert J; Routy JP; Jessen H; Kelleher AD; Hecht F; Sekaly RP; Carrington M; Walker BD; Allen TM; Rosenberg ES; Altfeld M, 2013, 'Temporal effect of HLA-B*57 on viral control during primary HIV-1 infection', Retrovirology, vol. 10, http://dx.doi.org/10.1186/1742-4690-10-139

Hsu DC; Kerr SJ; Iampornsin T; Pett SL; Avihingsanon A; Thongpaeng P; Zaunders JJ; Ubolyam S; Ananworanich J; Kelleher AD; Cooper DA, 2013, 'Restoration of CMV-Specific-CD4 T Cells with ART Occurs Early and Is Greater in Those with More Advanced Immunodeficiency', PLoS ONE, vol. 8, http://dx.doi.org/10.1371/journal.pone.0077479

Phetsouphanh C; Xu Y; Amin J; Seddiki N; Procopio F; Sekaly RP; Zaunders JJ; Kelleher AD, 2013, 'Characterization of Transcription Factor Phenotypes within Antigen-Specific CD4+ T Cells Using Qualitative Multiplex Single-Cell RT-PCR', PLoS ONE, vol. 8, http://dx.doi.org/10.1371/journal.pone.0074946

McBride K; Xu Y; Bailey M; Seddiki N; Suzuki K; Murray JM; Gao Y; Yan C; Cooper DA; Kelleher AD; Koelsch KK; Zaunders J, 2013, 'The majority of HIV type 1 DNA in circulating CD4⁺ T lymphocytes is present in non-gut-homing resting memory CD4⁺ T cells', AIDS Research and Human Retroviruses, vol. 29, pp. 1330 - 1339, http://dx.doi.org/10.1089/aid.2012.0351

Kent SJ; Reece JC; Petravic J; Martyushev A; Kramski M; De Rose R; Cooper DA; Kelleher AD; Emery S; Cameron PU; Lewin SR; Davenport MP, 2013, 'The search for an HIV cure: Tackling latent infection', The Lancet Infectious Diseases, vol. 13, pp. 614 - 621, http://dx.doi.org/10.1016/S1473-3099(13)70043-4

French MA; Center RJ; Wilson KM; Fleyfel I; Fernandez S; Schorcht A; Stratov I; Kramski M; Kent SJ; Kelleher AD, 2013, 'Isotype-switched immunoglobulin G antibodies to HIV Gag proteins may provide alternative or additional immune responses to 'protective' human leukocyte antigen-B alleles in HIV controllers', AIDS, vol. 27, pp. 519 - 528, http://dx.doi.org/10.1097/QAD.0b013e32835cb720

Tu E; Swenson LC; Land S; Pett S; Emery S; Marks K; Kelleher AD; Kaye S; Kaiser R; Schuelter E; Harrigan R, 2013, 'Results of external quality assessment for proviral DNA testing of HIV tropism in the Maraviroc switch collaborative study', Journal of Clinical Microbiology, vol. 51, pp. 2063 - 2071, http://dx.doi.org/10.1128/JCM.00510-13

Mee Ling Munier C; Kelleher AD; Kent SJ; De Rose R, 2013, 'The role of T cell immunity in HIV-1 infection', Current Opinion in Virology, vol. 3, pp. 438 - 446, http://dx.doi.org/10.1016/j.coviro.2013.05.009

Suzuki K; Hattori S; Marks K; Ahlenstiel C; Maeda Y; Ishida T; Millington M; Boyd M; Symonds G; Cooper DA; Okada S; Kelleher AD, 2013, 'Promoter Targeting shRNA Suppresses HIV-1 Infection In vivo Through Transcriptional Gene Silencing', Molecular Therapy - Nucleic Acids, vol. 2, pp. e137, http://dx.doi.org/10.1038/mtna.2013.64

Xu Y; Weatherall CJ; Bailey MR; Alcantara S; De Rose R; Estaquier J; Wilson KM; Suzuki K; Corbeil J; Cooper DA; Kent SJ; Kelleher AD; Zaunders J, 2013, 'Simian immunodeficiency virus infects follicular helper CD4 T cells in lymphoid tissues during pathogenic infection of pigtail macaques', Journal of Virology, vol. 87, pp. 3760 - 3773, http://dx.doi.org/10.1128/JVI.02497-12

Gilmore JB; Kelleher AD; Cooper DA; Murray JM, 2013, 'Explaining the determinants of first phase HIV decay dynamics through the effects of stage-dependent drug action', PLoS Computational Biology, vol. 9, pp. e1002971 (11pp), http://dx.doi.org/10.1371/journal.pcbi.1002971

Swaminathan S; Murray DD; Kelleher AD, 2013, 'Mirnas and HIV: Unforeseen Determinants Of Host-Pathogen Interaction', Immunological Reviews, vol. 254, pp. 265 - 280, http://dx.doi.org/10.1111/imr.12077Document

Seddiki N; Phetsouphanh C; Swaminathan S; Xu Y; Rao S; Li J; Sutcliffe E; Denyer G; Finlayson R; Gelgor L; Cooper DA; Zaunders J; Kelleher AD, 2013, 'The microRNA-9/B-lymphocyte-induced maturation protein-1/IL-2 axis is differentially regulated in progressive HIV infection', European Journal of Immunology, vol. 43, pp. 510 - 520, http://dx.doi.org/10.1002/eji.201242695

Porter K; Ewings FM; Ramjee G; Cooper DA; Fisher M; Schechter MT; Tambussi G; Kinloch-De Loes S; Miro J; Kelleher AD; Mcclure MO; Gabriel M; Phillips R; Weber J; Babiker AG, 2013, 'Short-course antiretroviral therapy in primary HIV infection', New England Journal of Medicine, vol. 368, pp. 207 - 217, http://dx.doi.org/10.1056/NEJMoa1110039

2012, 'Track A Basic Science', Journal of the International AIDS Society, vol. 15, http://dx.doi.org/10.7448/ias.15.5.18438

Kikuchi T; Iwabu Y; Kawana-Tachikawa A; Koga M; Hosoya N; Nomura S; Brumme ZL; Jessen H; Kelleher A; Markowitz M; Pereyra F; Trocha A; Walker BD; Iwamoto A; Tokunaga K; Miura T, 2012, 'Anti-APOBEC3G activity of HIV-1 Vif protein from elite controllers is attenuated compared to those from untreated chronic progressors or those from individuals with acute infection', JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, vol. 15, pp. 19 - 19, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000310588200043&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

French M; Center R; Wilson K; Fleyfel I; Fernandez S; Kelleher A, 2012, 'Natural control of HIV infection is associated with an isotype switched IgG antibody response to HIV core antigens in patients with 'non-protective' HLA-B alleles', JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, vol. 15, pp. 5 - 6, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000310588200010&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Kelleher AD; Cooper DA, 2012, 'Acute HIV infection', Sande's HIV/AIDS Medicine: Medical Management of AIDS 2013: Second Edition, pp. 77 - 88, http://dx.doi.org/10.1016/B978-1-4557-0695-2.00006-7

Jarrin I; Pantazis N; Gill MJ; Geskus R; Perez-Hoyos S; Meyer L; Prins M; Touloumi G; Johnson A; Hamouda O; de Olalla PG; Porter K; del Amo J; CASCADE Collaboration in EuroCoord , 2012, 'Uptake of combination antiretroviral therapy and HIV disease progression according to geographical origin in seroconverters in Europe, Canada, and Australia.', Clin Infect Dis, vol. 54, pp. 111 - 118, http://dx.doi.org/10.1093/cid/cir814

Cordery D; Martin A; Kelleher AD; Emery S; Cooper DA, 2012, 'The influence of HLA supertype on thymidine analogue associated with low peripheral fat in HIV.', AIDS, vol. 26, pp. 2337 - 2344, http://dx.doi.org/10.1097/QAD.0b013e32835ab213

Sasson SC; Zaunders J; Seddiki N; Mcbride K; Koelsch KK; Merlin KM; Smith DE; Cooper DA; Kelleher AD; Bailey MR, 2012, 'Progressive activation of CD127+132- recent thymic emigrants into terminally differentiated CD127-132+ T-cells in HIV-1 infection', PLoS One, vol. 7, pp. e31148, http://dx.doi.org/10.1371/journal.pone.0031148

Hsu DC; Zaunders J; Plit ML; Leeman C; Ip S; Iampornsin T; Pett SL; Bailey MR; Amin J; Ubolyam S; Avihingsanon A; Ananworanich J; Ruxrungtham K; Cooper DA; Kelleher AD, 2012, 'A novel assay detecting recall response to Mycobacterium tuberculosis: Comparison with existing assays', Tuberculosis, vol. 92, pp. 321 - 327, http://dx.doi.org/10.1016/j.tube.2012.03.008

Wren LH; Chung AW; Isitman G; Kelleher AD; Parsons MS; Amin J; Cooper DA; Stratov SI; Navis M; Kent SJ, 2012, 'Specific antibody-dependent cellular cytotoxicity responses associated with slow progression of HIV infection', Immunology, vol. 138, pp. 116 - 123, http://dx.doi.org/10.1111/imm.12016

Kramski M; Schorcht A; Johnston APR; Lichtfuss G; Jegaskanda S; De rose R; Stratov I; Kelleher AD; French MA; Center RJ; Jaworowski A; Kent SJ, 2012, 'Role of monocytes in mediating HIV-specific antibody-dependent cellular cytotoxicity', Journal of Immunological Methods, vol. 384, pp. 51 - 61, http://dx.doi.org/10.1016/j.jim.2012.07.006

Lodi S; Meyer L; Kelleher AD; Rosinska M; Ghosn J; Sannes M; Porter K, 2012, 'Immunovirologic Control 24 Months After Interruption of Antiretroviral Therapy Initiated Close to HIV Seroconversion', Annals of Internal Medicine, vol. 172, pp. 1252 - 1255, http://dx.doi.org/10.1001/archinternmed.2012.2719

Swaminathan S; Kelleher AD; Murray DD, 2012, 'The role of microRNAs in HIV-1 pathogenesis and therapy', AIDS, vol. 26, pp. 1325 - 1334, http://dx.doi.org/10.1097/QAD.0b013e328352adca

Brockman M; Chopera DR; Olvera A; Brumme C; Sela J; Markle TJ; Martin EPG; Carlson JM; Le AQ; Mcgovern R; Cheung PK; Kelleher AD; Jessen H; Markowitz M; Rosenberg E; Frahm N; Sanchez J; Mallal S; John M; Harrigan PR; Heckerman D; Brander C; Walker BD; Brummea ZL, 2012, 'Uncommon pathways of immune escape attenuate HIV-1 integrase replication capacity', Journal of Virology, vol. 86, pp. 6913 - 6923, http://dx.doi.org/10.1128/JVI.07133-11

Jaffe HW; De Stavola BL; Carpenter LM; Porter K; Cox DR; CASCADE Collaboration , 2011, 'Immune reconstitution and risk of Kaposi sarcoma and non-Hodgkin lymphoma in HIV-infected adults.', AIDS, vol. 25, pp. 1395 - 1403, http://dx.doi.org/10.1097/QAD.0b013e3283489c8b

Matthews PC; Leslie AJ; Katzourakis A; Crawford H; Payne R; Prendergast A; Power K; Kelleher AD; Klenerman P; Carlson J; Heckerman D; Ndung'u T; Walker BD; Allen TM; Pybus OG; Goulder PJR, 2011, 'HLA footprints on human immunodeficiency virus type 1 are associated with interclade polymorphisms and intraclade phylogenetic clustering', Journal of Virology, vol. 85, pp. 4635, http://dx.doi.org/10.1128/JVI.00375-11

Hemelaar J; Gouws E; Ghys PD; Osmanov S; WHO-UNAIDS Network for HIV Isolation and Characterisation , 2011, 'Global trends in molecular epidemiology of HIV-1 during 2000-2007.', AIDS, vol. 25, pp. 679 - 689, http://dx.doi.org/10.1097/QAD.0b013e328342ff93

Cordery DV; Humphries A; Amin J; Kelleher AD; Emery S; Cooper DA, 2011, 'The influence of HLA supertype on thymidine analogue induced body composition changes in STEAL', ANTIVIRAL THERAPY, vol. 16, pp. A20 - A21, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000294375900025&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Sutcliffe E; Bunting KL; He YQ; Li J; Phetsouphanh C; Seddiki N; Zafar A; Hindmarsh EJ; Parish CR; Kelleher AD; Mcinnes RL; Taya T; Milburn PJ; Rao S, 2011, 'Chromatin-Associated Protein Kinase C-è Regulates an Inducible Gene Expression Program and MicroRNAs in Human T Lymphocytes', Molecular Cell, vol. 41, pp. 704 - 719, http://dx.doi.org/10.1016/j.molcel.2011.02.030

Sauce D; Larsen M; Fastenackels S; Pauchard M; Ait-mohand H; Schneider L; Guihot A; Boufassa F; Zaunders J; Iguertsira M; Bailey M; Gorochov G; Duvivier C; Carcelain G; Kelleher AD; Simon A; Meyer L; Costagliola D; Deeks SG; Lambotte O; Autran B; Hunt P; Katlama C; Appay V, 2011, 'HIV disease progression despite suppression of viral replication is associated with exhaustion of lymphopoiesis', Blood, vol. 117, pp. 5142 - 5151, http://dx.doi.org/10.1182/blood-2011-01-331306

Murray JM; Kelleher ; Cooper DA, 2011, 'Timing of the components of the HIV life cycle in productively infected CD4+ T cells in a population of HIV-infected individuals', Journal of Virology, vol. 85, pp. 10798 - 10805, http://dx.doi.org/10.1128/JVI.05095-11

Byakwaga H; Purcell DJ; French MA; Amin J; Lewin S; Haskelberg H; Kelleher AD; Garsia RJ; Boyd MA; Cooper DA; Emery S, 2011, 'Intensification of antiretroviral therapy with raltegravir or addition of hyperimmune bovine colostrum in HIV-infected patients with suboptimal CD4 + T-cell response: A randomized controlled trial', Journal of Infectious Diseases, vol. 204, pp. 1532 - 1540, http://dx.doi.org/10.1093/infdis/jir559

Van Bockel DJ; Ammaranond P; Petoumenos K; Mcmurchie M; Finlayson RJ; Middleton MG; Davenport ; Venturi V; Suzuki K; Gelgor L; Kaldor JM; Cooper DA; Kelleher AD, 2011, 'HIV immune escape at an immunodominant epitope in HLA-B*27-positive individuals predicts viral load outcome', Journal of Immunology, vol. 186, pp. 479 - 488, http://dx.doi.org/10.4049/jimmunol.0903227

Iglesias MA; Almeida JR; Fastenackels S; Van Bockel DJ; Hashimoto M; Venturi V; Gostick E; Urrutia A; Wooldridge L; Clement M; Gras S; Wilmann P; Autran B; Moris A; Rossjohn J; Davenport MP; Takiguchi M; Brander C; Douek D; Kelleher AD; Price DA; Appay V, 2011, 'Escape from highly effective public CD8+ T-cell clonotypes by HIV', Blood, vol. 118, pp. 2138 - 2149, http://dx.doi.org/10.1182/blood-2011-01-328781

Munier CM; Andersen CR; Kelleher , 2011, 'HIV vaccines: Progress to date', Drugs, vol. 71, pp. 387 - 414, http://dx.doi.org/10.2165/11585400-000000000-00000

Sirivichayakul S; Thantiworasit P; Chatkulkawin P; Buranapraditkun S; Munier ML; Kelleher AD; Ruxrungtham K, 2011, 'Immunogenicity assay validation for an HIV vaccine trial: High IFNã+/IL-2+ CD8+ T cells background in healthy Thais', Vaccine, vol. 29, pp. 6002 - 6007, http://dx.doi.org/10.1016/j.vaccine.2011.06.035

Suzuki K; Ishida T; Yamagishi M; Ahlenstiel C; Swaminathan S; Marks K; Murray D; McCartney EM; Beard MR; Alexander M; Purcell DF; Cooper DA; Watanabe T; Kelleher AD, 2011, 'Transcriptional gene silencing of HIV-1 through promoter targeted RNA is highly specific.', RNA biology, vol. 8, pp. 1035 - 1046

Chung AW; Navis M; Isitman G; Centre R; Finlayson RJ; Bloch M; Gelgor L; Kelleher AD; Kent SJ; Stratov I, 2011, 'Activation of NK cells by ADCC responses during early HIV infection', Viral Immunology, vol. 24, pp. 171 - 175, http://dx.doi.org/10.1089/vim.2010.0108

Swaminathan S; Hood CL; Suzuki K; Kelleher AD, 2010, 'RNA duplexes in transcriptional regulation', Biomolecular Concepts, vol. 1, pp. 285 - 296, http://dx.doi.org/10.1515/bmc.2010.021

French MA; Tanaskovic S; Law MG; Lim A; Fernandez S; Ward LD; Kelleher AD; Emery S, 2010, 'Vaccine-induced IgG2 anti-HIV p24 is associated with control of HIV in patients with a 'high-affinity' FcγRIIa genotype', AIDS, vol. 24, pp. 1983 - 1990, http://dx.doi.org/10.1097/QAD.0b013e32833c1ce0

Arnott A; Jardine D; Wilson K; Gorry P; Merlin K; Grey PA; Law MG; Dax E; Kelleher AD; Smith DE; Mcphee D, 2010, 'High viral fitness during acute HIV-1 infection', PLoS One, vol. 5, pp. e12631, http://dx.doi.org/10.1371/journal.pone.0012631

Brockman M; Brumme ZL; Brumme CJ; Miura T; Sela J; Rosato PC; Kadie CM; Carlson JM; Markle TJ; Streeck H; Kelleher AD; Markowitz M; Jessen H; Rosenberg E; Atfeld M; Harrigan PR; Heckerman D; Walker BD; Allen TM, 2010, 'Early selection in Gag by protective HLA alleles contributes to reduced HIV-1 replication capacity that may be largely compensated for in chronic infection', Journal of Virology, vol. 84, pp. 11937 - 11949, http://dx.doi.org/10.1128/JVI.01086-10

Tong WW; McAllister J; White PA; Kelleher A; Carr A, 2010, 'Transmission of triple-class, drug resistant HIV-1 in Australia', Internal Medicine Journal, vol. 40, pp. 657 - 661, http://dx.doi.org/10.1111/j.1445-5994.2010.02296.x

Miura T; Brumme ZL; Brockman MA; Rosato P; Sela J; Brumme CJ; Pereyra F; Kaufmann DE; Trocha A; Block BL; Daar ES; Connick E; Jessen H; Kelleher AD; Rosenberg E; Markowitz M; Schafer K; Vaida F; Iwamoto A; Little S; Walker BD, 2010, 'Impaired replication capacity of acute/early viruses in persons who become HIV controllers', Journal of Virology, vol. 84, pp. 7581 - 7591, http://dx.doi.org/10.1128/JVI.00286-10

Pett SL; Zaunders J; Bailey M; Murray JM; Macrae K; Emery S; Cooper DA; Kelleher AD, 2010, 'A novel Chemokine-Receptor-5 (CCR5) blocker, SCH532706, has differential effects on CCR5+CD4+ and CCR5+CD8+ T cell numbers in chronic HIV infection', AIDS Research and Human Retroviruses, vol. 26, pp. 653 - 661, http://dx.doi.org/10.1089/aid.2009.0278

Pett SL; Emery S; Kelleher AD; Cooper DA, 2010, 'Antiretroviral agents: Focus on Maraviroc for the Treatment of HIV-1-Infected Adults', Clinical Medicine Insights: Therapeutics, vol. 2, pp. CMT.S5420 - CMT.S5420, http://dx.doi.org/10.4137/cmt.s5420

Koelsch KK; Xu Y; Bailey M; McBride K; Seddiki N; Suzuki K; Murray J; Cooper DA; Kelleher AD; Zaunders J, 2010, 'Most HIV DNA in PBMC is present in non-gut homing, resting memory CD4+ T cells with a ß7-CD38-CD127 high phenotype', Journal of the International AIDS Society, vol. 13, pp. O2 - O2, http://dx.doi.org/10.1186/1758-2652-13-s3-o2

Venturi V; Chin HY; Asher TE; Ladell K; Scheinberg P; Bornstein E; Van Bockel D; Kelleher AD; Douek DC; Price DA; Davenport MP, 2009, 'TCR β-chain sharing in human CD8⁺ T cell responses to cytomegalovirus and EBV', Journal of Immunology, vol. 181, pp. 7853 - 7862, http://dx.doi.org/10.4049/jimmunol.181.11.7853

Reddy SMR; Center RJ; Suzuki K; Gorry P; Kelleher A; Purcell DF, 2009, 'P12-01. Construction and characterization of recombinant envelope glycoproteins derived from HIV-1 pre-seroconversion strains as potential vaccine immunogens', Retrovirology, vol. 6, http://dx.doi.org/10.1186/1742-4690-6-S3-P167

Reddy SMR; Center RJ; Suzuki K; Gorry P; Kelleher A; Purcell DF, 2009, 'Construction and characterization of recombinant envelope glycoproteins derived from HIV-1 pre-seroconversion strains as potential vaccine immunogens', RETROVIROLOGY, vol. 6, http://dx.doi.org/10.1186/1742-4690-6-S3-P167

Swaminathan S; Zaunders J; Wilkinson J; Suzuki K; Kelleher AD, 2009, 'Does the presence of anti-HIV miRNAs in monocytes explain their resistance to HIV-1 infection?', Blood, vol. 113, pp. 5029 - 5030, http://dx.doi.org/10.1182/blood-2009-01-196741

Matthews PM; Leslie A; Katzourakis A; Crawford H; Payne R; Prendergast A; Power KA; Kelleher AD; Klenerman P; Carlson J; Heckerman D; Ndung''u T; Walker BD; Allen TM; Pybus O; Goulder PJ, 2009, 'HLA Footprints on Human Immunodeficiency Virus Type 1 Are Associated with Interclade Polymorphisms and Intraclade Phylogenetic Clustering', Journal of Virology, vol. 83, pp. 4605 - 4615, http://jvi.asm.org/content/85/9/4635

Zaunders J; Munier ML; Seddiki N; Pett SL; Ip S; Bailey M; Xu Y; Brown KJ; Dyer W; Kim MS; De Rose R; Kent SJ; Jiang L; Breit SN; Emery S; Cunningham AL; Cooper DA; Kelleher AD, 2009, 'High levels of human antigen-specific CD4+ T cells in peripheral blood revealed by stimulated coexpression of CD25 and CD134 (OX40)', Journal of Immunology, vol. 183, pp. 2827 - 2836, http://dx.doi.org/10.4049/jimmunol.0803548

Schneidewind A; Brumme Z; Brumme C; Power KA; Reyor L; O Sullivan K; Gladden A; Hempel U; Kuntzen T; Wang YE; Oniangue-Ndza C; Jessen H; Markowitz M; Rosenberg E; Sekaly R; Kelleher AD; Walker BD; Allen TM, 2009, 'Transmission and long-term stability of compensated CD8 escape mutations', Journal of Virology, vol. 83, pp. 3993 - 3997, http://dx.doi.org/10.1128/JVI.01108-08

Byakwaga H; Murray JM; Petoumenos K; Kelleher AD; Law MG; Boyd MA; Emery S; Mallon PW; Cooper DA, 2009, 'Evolution of CD4+T cell count in HIV-1-infected adults receiving antiretroviral therapy with sustained long-term virological suppression', AIDS Research and Human Retroviruses, vol. 25, pp. 569 - 576, http://dx.doi.org/10.1089/aid.2008.0149

Seddiki N; Sasson SC; Santner-Nanan B; Munier M; Van Bockel DJ; Ip S; Marriott D; Pett SL; Nanan R; Cooper DA; Zaunders J; Kelleher AD, 2009, 'Proliferation of weakly suppressive regulatory CD4+ T cells is associated with over-active CD4+ T-cell responses in HIV-positive patients with mycobacterial immune restoration disease', European Journal of Immunology, vol. 39, pp. 391 - 403, http://dx.doi.org/10.1002/eji.200838630

Weatherall CJ; Kelleher AD; Cooper DA, 2009, 'Trials and tribulations of HIV vaccines', Future Hiv Therapy, vol. 3, pp. 145 - 160, http://dx.doi.org/10.2217/17584310.3.2.145

Yamagishi M; Ishida T; Miyake A; Cooper DA; Kelleher AD; Suzuki K; Watanabe T, 2009, 'Retroviral delivery of promoter-targeted shRNA induces long-term silencing of HIV-1 transcription', Microbes and Infection, vol. 11, pp. 500 - 508, http://dx.doi.org/10.1016/j.micinf.2009.02.003

Suzuki K; Kelleher AD, 2009, 'Transcriptional regulation by promoter targeted RNAs', Current Topics in Medicinal Chemistry, vol. 9, pp. 1079 - 1087, http://dx.doi.org/10.2174/156802609789630875

Streeck H; Jolin J; Qi YC; Yassine-Diab B; Johnson ; Kwon D; Addo M; Brumme C; Routy J; Little S; Jessen H; Kelleher AD; Hecht FM; Sekaly R; Rosenberg E; Walker BD; Carrington M; Altfeld M, 2009, 'Human immunodeficiency virus type 1-specific CD8+ T-cell responses during primary infection are major determinants of the viral set point and loss of CD4+ T cells', Journal of Virology, vol. 83, pp. 7641 - 7648, http://dx.doi.org/10.1128/JVI.00182-09

Munier CM; Zaunders J; Ip S; Cooper DA; Kelleher AD, 2009, 'A culture amplified multi-parametric intracellular cytokine assay (CAMP-ICC) for enhanced detection of antigen specific T-cell responses', Journal of Immunological Methods, vol. 345, pp. 1 - 16, http://dx.doi.org/10.1016/j.jim.2009.03.013

Matthews PM; Leslie A; Katzourakis A; Crawford H; Payne R; Prendergast A; Power KA; Kelleher AD; Klenerman P; Carlson J; Heckerman D; Ndung''u T; Walker BD; Allen TM; Pybus O; Goulder PJ, 2009, 'HLA Footprints on human immunodeficiency virus tp 1 are associated with interclade polymorphisms and intraclade phylogenetic clustering', Journal of Virology, vol. 83, pp. 4605 - 4615, http://dx.doi.org/10.1128/JVI.02017-08

Hamilton AR; Kelleher AD; Marriott D, 2009, 'Unusual association of diseases/symptoms: A case of severe visceral leishmaniasis resulting from travel to Greece', BMJ Case Reports, http://dx.doi.org/10.1136/bcr.06.2009.2036

Pantazis N; Touloumi G; Vanhems P; Gill J; Bucher HC; Porter K; CASCADE Collaboration , 2008, 'The effect of antiretroviral treatment of different durations in primary HIV infection.', AIDS, vol. 22, pp. 2441 - 2450, http://dx.doi.org/10.1097/QAD.0b013e328319ea4e

Pett S; Zaunders J; Bailey M; Cooper D; MacRae K; Emery S; Kelleher A, 2008, 'Changes in CCR5+ cells and antigen-specific CD4+ T-cells during monotherapy with a CCR5 antagonist SCH532706 compared with combination therapy', Journal of the International AIDS Society, vol. 11, pp. p297, http://dx.doi.org/10.1186/1758-2652-11-s1-p297

Jarrin I; Geskus R; Bhaskaran K; Prins M; Perez-Hoyos S; Muga R; Hernández-Aguado I; Meyer L; Porter K; Amo JD; Bucher H; Chêne G; Pillay D; Rosinska M; Sabin C; Touloumi G; del Amo J; Meyer L; Chêne G; Pillay D; Sabin C; Touloumi G; Porter K; Walker S; Babiker A; Darbyshire J; de Luca A; Fisher M; Goujard C; Muga R; Kaldor J; Kelleher T; Gelgor L; Ramacciotti T; Cooper D; Smith D; Gill J; Bruun Jørgensen L; Nielsen C; Pedersen C; Lutsar I; Chêne G; Dabis F; Thiebaut R; Masquelier B; Costagliola D; Vanhems P; Boufassa F; Hamouda O; Kucherer C; Touloumi G; Pantazis N; Hatzakis A; Paraskevis D; Karafoulidou A; Rezza G; Dorrucci M; Longo B; Balotta C; van Asten L; van der Bij A; Coutinho R; Sannes M; Brubakk O; Eskild A; Bruun JN; Camacho R; Smolskaya T; Muga R; Tor J; de Olalla PG; Caylà J; del Romero J; Belda J; Rickenbach M; Francioli P; Malyuta R; Brettle R; Delpech V; Lattimore S; Murphy G; Parry J; Gill N; Lee C; Porter K; Johnson A; Phillips A, 2008, 'Gender differences in HIV progression to AIDS and death in industrialized countries: Slower disease progression following HIV seroconversion in women', American Journal of Epidemiology, vol. 168, pp. 532 - 540, http://dx.doi.org/10.1093/aje/kwn179

Bhaskaran K; Hamouda O; Sannes M; Boufassa F; Johnson AM; Lambert PC; Porter K; CASCADE Collaboration , 2008, 'Changes in the risk of death after HIV seroconversion compared with mortality in the general population.', JAMA, vol. 300, pp. 51 - 59, http://dx.doi.org/10.1001/jama.300.1.51

Seddiki N; Kelleher AD, 2008, 'Regulatory T cells in HIV infection: Who's suppressing what?', Current Infectious Disease Reports, vol. 10, pp. 252 - 258, http://dx.doi.org/10.1007/s11908-008-0041-8

Seddiki N; Kelleher AD, 2008, 'Regulatory T cells in HIV infection: Who's suppressing what?', Current HIV/AIDS Reports, vol. 5, pp. 20 - 26, http://dx.doi.org/10.1007/s11904-008-0004-6

McElrath MJ; De Rosa SC; Moodie Z; Dubey S; Kierstead L; Janes H; Defawe OD; Carter DK; Hural J; Akondy R; Buchbinder SP; Robertson MN; Mehrotra DV; Self SG; Corey L; Shiver JW; Casimiro DR, 2008, 'HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis', The Lancet, vol. 372, pp. 1894 - 1905, http://dx.doi.org/10.1016/S0140-6736(08)61592-5

Seddiki N; Kelleher AD, 2008, 'Regulatory T cell abnormalities are associated with aberrant CD4+ T cell responses in patients with immune inflammatory syndrome (IRIS)', Clinical Immunology, vol. 127, pp. S126 - S127, http://dx.doi.org/10.1016/j.ctim.2008.03.359

Chessman D; Kostenko L; Lethborg T; Purcell A; Williamson N; Chen Z; Kjer-Nielsen L; Mifsud N; Tait B; Holdsworth R; Almeida C; Nolan D; Macdonalds W; Archbold J; Kelleher AD; Marriott D; Mallal SA; Bharadwaj M; Rossjohn J; McCluskey J, 2008, 'Human leukocyte antigen class I-restricted activation of CD8(+) T cells provides the immunogenetic basis of a systemic drug hypersensitivity', Immunity, vol. 28, pp. 822 - 832, http://dx.doi.org/10.1016/j.immuni.2008.04.020

Lewin S; Murray JM; Solomon A; Wightman F; Cameron P; Purcell DJ; Zaunders J; Grey PA; Bloch M; Smith DE; Cooper DA; Kelleher AD, 2008, 'Virologic determinants of success after structured treatment interruptions in antiretrovirals in acute HIV-1 infection', JAIDS: Journal of Acquired Immune Deficiency Syndromes, vol. 47, pp. 140 - 147, http://dx.doi.org/10.1097/QAI.0b013e31815dbf7f

Mallon PW; Sedwell R; Rogers GJ; Nolan D; Unemori P; Hoy JF; Samaras K; Kelleher AD; Emery S; Cooper DA; Carr AD, 2008, 'Effect of Rosiglitazone on Peroxisome Proliferator-Activated Receptor gamma Gene Expression in Human Adipose Tissue Is Limited by Antiretroviral Drug-Induced Mitochondrial Dysfunction', Journal of Infectious Diseases, vol. 198, pp. 1794 - 1803, http://dx.doi.org/10.1086/593179

Suzuki K; Juelich T; Lim H; Ishida T; Watanebe T; Cooper DA; Rao S; Kelleher AD, 2008, 'Closed chromatin architecture is induced by an RNA duplex targeting the HIV-1 promoter region', The Journal of Biological Chemistry, vol. 283, pp. 23353 - 23363, http://dx.doi.org/10.1074/jbc.M709651200

Lim H; Suzuki K; Cooper DA; Kelleher AD, 2008, 'Promoter-targeted siRNAs induce gene silencing of simian immunodeficiency virus (SIV) infection in vitro', Molecular Therapy, vol. 16, pp. 565 - 570, http://dx.doi.org/10.1038/sj.mt.6300380

Venturi V; Chin HY; Asher TE; Ladell K; Scheinberg P; Bornstein E; van Bockel D; Kelleher AD; Douek DC; Price DA; Davenport MP, 2008, 'TCR beta-chain sharing in human CD8+ T cell responses to cytomegalovirus and EBV', Journal of Immunology, vol. 181, pp. 7853 - 7862

De Rose R; Mason RS; Loh L; Peut V; Smith MZ; Fernandez CS; Alcantara S; amarasena T; Reece J; Seddiki N; Kelleher AD; Zaunders J; Kent SJ, 2008, 'Safety, immunogenicity and efficacy of peptide-pulsed cellular immunotherapy in macaques.', Journal of Medical Primatology, vol. 37, pp. 69 - 78, http://dx.doi.org/10.1111/j.1600-0684.2008.00329.x

Mason R; De Rose R; Seddiki N; Kelleher AD; Kent SJ, 2008, 'Low pre-infection levels and loss of central memory CD4+T cells may predict rapid progression in SIV-infected pigtail macaques', Virology, vol. 381, pp. 11 - 15, http://dx.doi.org/10.1016/j.virol.2008.08.042

Kelleher AD; Purcell D, 2008, 'Controlling HIV infection HIV co-receptor gets the finger', Immunology and Cell Biology, vol. 86, pp. 641 - 642, http://dx.doi.org/10.1038/icb.2008.68

Brumme Z; Brumme C; Carlson J; Streeck H; John M; Eichbaum Q; Block B; Baker B; Kadie C; Markowitz M; Jessen H; Kelleher AD; Rosenberg E; Kaldor JM; Yuki Y; Carrington M; Allen TM; Mallal SA; Altfeld M; Heckerman D; Walker BD, 2008, 'Marked epitope- and allele- specific differences in rates of mutation in human immunodeficiency type 1 (HIV-1) Gag, Pol, and Nef cytotoxic T-lymphocyte epitopes in acute/early HIV-1 infection', Journal of Virology, vol. 82, pp. 9216 - 9227, http://dx.doi.org/10.1128/JVI.01041-08

Burton C; Goodall R; Samri A; Autran B; Kelleher AD; Poli G; Pantaleo G; Gotch F; Imami N, 2008, 'Restoration of anti-tetanus toxoid responses in patients initiating highly active antiretroviral therapy with or without a boost immunization: an INITIO substudy', Clinical and Experimental Immunology, vol. 152, pp. 252 - 257, http://dx.doi.org/10.1111/j.1365-2249.2008.03611.x

Falster KA; Gelgor L; Shaik A; Zablotska Manos I; Prestage G; Grierson J; Thorpe R; Pitts M; Anderson JS; Chuah J; Mulhall BP; Petoumenos K; Kelleher AD; Law MG, 2008, 'Trends in antiretroviral treatment use and treatment response in three Australian states in the first decade of combination antiretroviral treatment', Sexual Health, vol. 5, pp. 141 - 154, http://dx.doi.org/10.1071/SH07082

Santner-Nanan B; Seddiki N; Zhu E; Quent V; Kelleher AD; Fazekas de St Groth B; Nanan R, 2008, 'Accelerated age-dependent transition of human regulatory T cells to effector memory phenotype', International Immunology, vol. 20, pp. 375 - 383, http://dx.doi.org/10.1093/intimm/dxm151

Streeck H; Van Bockel DJ; Kelleher AD, 2008, 'T-cell responses in primary HIV-1 infection. .', Current opinion in HIV & AIDS, vol. 3, pp. 52 - 59, http://dx.doi.org/10.1097/COH.0b013e3282f269d6

Zaunders J; Jing J; Leipold M; Maecker H; Kelleher AD; Koch I, 2007, 'Computationally efficient multidimensional analysis of complex flow cytometry data using second order polynomial histograms', Cytometry Part A, vol. 89, pp. 44 - 58, http://dx.doi.org/10.1002/cyto.a.22704

Venturi V; Chin H; Asher T; Ladell K; Scheinberg P; Bornstein E; Van Bockel DJ; Kelleher AD; Douek DC; Price DA; Davenport MP, 2007, 'T cell receptor b-chain sharing in human CD8+ T cell responses to cytomegalovirus and Epstein-Barr virus', Journal of Immunology, vol. 181, pp. 7853 - 7862

Schneidewind A; Brockman M; Yang R; Adam RI; Li B; Le Gall S; Rinaldo C; Craggs SL; Allgaier RL; Power KA; Kuntzen T; Tung C; LaBute MX; Mueller SC; Harrer T; Mcmichael AJ; Goulder PJ; Aiken CM; Brander C; Kelleher AD; Allen TM, 2007, 'Escape from the Dominant HLA-B27-Restricted Cytotoxic T-Lymphocyte Response in Gag Is Associated with a Dramatic Reduction in Human Immunodeficiency Virus Type 1 Replication', Journal of Virology, vol. 81, pp. 12382 - 12393, http://dx.doi.org/10.1128/JVI.01543-07

Murray JM; Emery S; Kelleher AD; Law MG; Chen J; Hazuda DJ; Nguyen BT; Teppler H; Cooper DA, 2007, 'Antiretroviral therapy with the integrase inhibitor raltegravir alters decay kinetics of HIV, significantly reducing the second phase', AIDS, vol. 21, pp. 2315 - 2321, http://dx.doi.org/10.1097/QAD.0b013e3282f12377

Emery S; Kelleher AD; Workman C; Puls R; Bloch MT; Baker D; Hoy JF; Ip S; Nalliah K; Ward L; Law MG; Cooper DA, 2007, 'Influence of IFN gamma co-expression on the safety and antiviral efficacy of recombinant fowlpox virus HIV therapeutic vaccines following interruption of antiretroviral therapy', Human Vaccines, vol. 3, pp. 260 - 267, http://dx.doi.org/10.4161/hv.4627

van Bockel D; Price DA; Asher TE; Venturi V; Suzuki K; Warton K; Davenport MP; Cooper DA; Douek DC; Kelleher AD, 2007, 'Validation of RNA-based molecular clonotype analysis for virus-specific CD8+ T-cells in formaldehyde-fixed specimens isolated from peripheral blood', Journal of Immunological Methods, vol. 326, pp. 127 - 138, http://dx.doi.org/10.1016/j.jim.2007.07.016

Munier CM; Kelleher AD, 2007, 'Acutely dysregulated, chronically disabled by the enemy within: T-cell responses to HIV-1 infection', Immunology and Cell Biology, vol. 85, pp. 6 - 15, http://dx.doi.org/10.1038/sj.icb.7100015

Dyer W; Pett SL; Sullivan JS; Emery S; Cooper DA; Kelleher AD; Lloyd AR; Lewin S, 2007, 'Substantial improvements in performance indicators achieved in a peripheral blood mononuclear cell cryopreservation quality assurance program using single donor samples', Clinical and Vaccine Immunology, vol. 14, pp. 52 - 59, http://dx.doi.org/10.1128/CVI.00214-06

Streeck H; Lichterfeld M; Alter G; Meier A; Teigen N; Yassine-Diab B; Sidhu H; Little S; Kelleher AD; Routy J; Rosenberg E; Sekaly R; Walker BD; Altfeld M, 2007, 'Recognition of a defined region within p24 Gag by CD8(+) T cells during primary human immunodeficiency virus type I infection in individuals expressing protective HLA class I alleles', Journal of Virology, vol. 81, pp. 7725 - 7731, http://dx.doi.org/10.1128/JVI.00708-07

Kaufmann D; Kavanagh D; Pereyra F; Zaunders J; Mackey E; Miura T; Palmer S; Brockman M; Rathod A; Piechocka-Trocha A; Baker B; Zhu B; Le Gall S; Waring M; Ahern R; Moss K; Kelleher AD; Coffin J; Freeman G; Rosenberg E; Walker BD, 2007, 'Upregulation of CTLA-4 by HIV-specific CD4(+) T cells correlates with disease progression and defines a reversible immune dysfunction', Nature Immunology, vol. 8, pp. 1246 - 1254, http://dx.doi.org/10.1038/ni1515

Samri A; Goodall RL; Burton C; Imami N; Pantaleo G; Kelleher AD; Poli G; Gotch F; Autran B, 2007, 'Three-year immune reconstitution in PI-sparing and PI-containing antiretroviral regimens in advanced HIV-1 disease', Antiviral Therapy, vol. 12, pp. 553 - 558

Lin BB; Gladden A; Altfeld M; Kaldor JM; Cooper DA; Kelleher AD; Allen TM, 2007, 'Rapid Reversion of Sequence Polymorphisms Dominates Early Human Immunodeficiency Virus Type 1 Evolution', Journal of Virology, vol. 81, pp. 193 - 201, http://dx.doi.org/10.1128/JVI.01231-06

Hemelaar J; Gouws E; Ghys PD; Osmanov S, 2006, 'Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004.', AIDS, vol. 20, pp. W13 - W23, http://dx.doi.org/10.1097/01.aids.0000247564.73009.bc

Kelleher AD; Zaunders J, 2006, 'Decimated or missing in action:CD4+ T cells as targets and effectors in the pathogenesis of primary HIV infection. Curr HIV/AIDS Rep 2006;3(1):5-12.', Current HIV/AIDS Reports, vol. 3, pp. 5 - 12

Bloch MT; Smith DE; Quan D; Kaldor JM; Zaunders J; Petoumenos K; Irvine K; Law MG; Grey PA; Finlayson R; Mcfarlane R; Kelleher AD; Carr AD; Cooper DA, 2006, 'The role of hydroxyurea in enhancing the virologic control achieved through structured treatment interruption in primary HIV infection: Final results from a randomized clinical trial (Pulse)', JAIDS: Journal of Acquired Immune Deficiency Syndromes, vol. 42, pp. 192 - 202, http://dx.doi.org/10.1097/01.qai.0000219779.50668.e6

Sasson SC; Zaunders J; Kelleher AD, 2006, 'The IL-7/IL-7 receptor axis: understanding its central role in T-cell homeostatis and the challenges facing its utilization as a novel therapy. 2006;7:1571-1582.', Current Drug Targets, vol. 7, pp. 1571 - 1582, http://dx.doi.org/10.2174/138945006779025365

Zaunders J; Ip S; Munier CM; Munier M; Kaufmann D; Suzuki K; Brereton C; Seddiki N; Sasson SC; Koelsch KK; Landay A; Grey PA; Finlayson R; Kaldor JM; Rosenberg E; Walker BD; Fazekas de St Groth B; Cooper DA; Kelleher AD, 2006, 'Infection of CD127(+) (Interleukin-7 receptor+) CD4+ cells and overexpression of CTLA-4 are linked to loss of antigen-specific CD4 T cells during primary human immunodeficiency virus type 1 infection', Journal of Virology, vol. 80, pp. 10162 - 10172, http://dx.doi.org/10.1128/JVI.00249-06

Sasson SC; Zaunders J; Zanetti G; King E; Merlin K; Smith DE; Stanley K; Cooper DA; Kelleher AD, 2006, 'Increased plasma interleukin-7 level correlates with decreased CD127 and increased CD132 extracellular expression on T cell subsets in patients with HIV-1 infection', Journal of Infectious Diseases, vol. 193, pp. 505 - 514, http://dx.doi.org/10.1086/499309

De Rose R; Sullivan MT; Dale CJ; Kelleher AD; Emery S; Cooper DA; Ramshaw I; Boyle D; Kent SJ, 2006, 'Dose-response relationship of DNA and recombinant fowlpox virus prime-boost HIV vaccines.', Human Vaccines, vol. 2, pp. 134 - 136

Barbour J; Hecht FM; Little S; Markowitz M; Daar E; Kelleher AD; Routy J; Campbell T; Rosenberg E; Segal M; Weidler J; Grant R, 2006, 'Greater CD4 T-cell gains after one year of antiretroviral therapy are associated with lower HIV-1 pol replication capacity.', AIDS, vol. 20, pp. 2123 - 2125, http://dx.doi.org/10.1097/01.aids.0000247583.38943.95

Zaunders J; Dyer W; Munier CM; Ip S; Liu J; Amyes E; Rawlinson WD; Rose RJ; Kent SJ; Sullivan JS; Cooper DA; Kelleher AD, 2006, 'CD127+CCR5+CD38+++CD4+ Th1 Effector Cells Are an Early Component of the Primary Immune Response to Vaccinia Virus and Precede Development of Interleukin-2+ Memory CD4+ T Cells', Journal of Virology, vol. 80, pp. 10151 - 10161, http://dx.doi.org/10.1128/JVI.02670-05

Kelleher AD; Zaunders J, 2006, 'Decimated or missing in action:CD4+ T cells as targets and effectors in the pathogenesis of primary HIV infection. Curr HIV/AIDS Rep 2006;3(1):5-12.', Current HIV/AIDS Reports, vol. 3, pp. 5 - 12, http://dx.doi.org/10.1007/s11904-006-0002-5

Carlin S; Moore JJ; Zaunders J; Kelleher AD; Ma DD, 2006, 'T lineage differentiation in vitro of adult Haematopoietic Stem Cells', CYTOMETRY PART A, vol. 69A, pp. 399 - 400, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000237187700018&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Seddiki N; Santner-Nanan B; Martinson J; Zaunders J; Sasson SC; Landay A; Solomon MJ; Selby W; Alexander S; Nanan R; Kelleher AD; Fazekas de St Groth B, 2006, 'Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells', Journal of Experimental Medicine, vol. 203, pp. 1693 - 1700, http://dx.doi.org/10.1084/jem.20060468

Hales GP; Birch C; Crowe S; Workman C; Hoy JF; Kelleher AD; Lincoln D; Lincoln D; Law MG; Emery S, 2006, 'A randomised trial comparing genotypic and virtual phenotypic interpretation of HIV drug resistance: The CREST study.', PLoS Clinical Trials, vol. 1, pp. e18, http://dx.doi.org/10.1371/journal.pctr.0010018

Fazekos de St Groth B; Seddiki N; Santner-Nanan B; Martinson J; Zaunders J; Sasson SC; Landay A; Nanan R; Kelleher AD, 2006, 'Expression of IL-2 and IL-7 receptors discriminates between human regulatory and activated T-cells within CD45RA and CD45RO compartments', Clinical Immunology, vol. 119, pp. S7 - S7, http://dx.doi.org/10.1016/j.clim.2006.04.010

Kelleher AD; Puls R; Bebbington M; Boyle D; Kent S; Kippax SC; Purcell D; Thomson S; Wand HC; Cooper DA; Emery S; Ffrench RA, 2006, 'A randomized, placebo-controlled phase I trial of DNA prime, recombinant fowlpox virus boost prophylactic vaccine for HIV-1', AIDS, vol. 20, pp. 294 - 297, http://dx.doi.org/10.1097/01.aids.0000199819.40079.e9

Suzuki K; Shijuuku T; Fukamachi T; Zaunders J; Guillemin GJ; Cooper DA; Kelleher AD, 2005, 'Prolonged transcriptional silencing and CpG methylation induced by siRNAs targeted to the HIV-1 promoter region.', Journal of RNAi and Gene Silencing, vol. 1, pp. 66 - 78

Sasson SC; Kelleher AD; Cooper DA, 2005, 'The modern ART of HIV infection management: Towards a tailored approach to maximize CD4 T cell reconstitution', Clinical Infectious Diseases, vol. 41, pp. 373 - 375, http://dx.doi.org/10.1086/431489

Emery S; Workman C; Puls R; Bloch M; Baker D; Bodsworth NJ; Anderson JA; Crowe SM; Hoy JF; Aichelburg A; Ward LA; Boyle D; Law MG; Kelleher AD; Cooper DA, 2005, 'Randomised, Placebo-Controlled, Phase 1/2a Evaluation of the Safety and Immunogenicity of Fowlpox Virus Expressing HIV gag-pol and Interferon-y in HIV-1 Infected Subjects', Human Vaccines, vol. 1, pp. 232 - 238, http://dx.doi.org/10.4161/hv.1.6.2342

Mallon PW; Sedwell R; Unemori P; Kelleher AD; Cooper DA; Carr AD, 2005, 'Methodological considerations in human studies of gene expression in HIV-associated lipodystrophy', Antiviral Therapy, vol. 10, pp. M101 - M108

Mallon PW; Unemori P; Sedwell R; Morey AL; Rafferty M; Williams KM; Chisholm DJ; Samaras K; Emery S; Kelleher AD; Cooper DA; Carr AD, 2005, 'In vivo, nucleoside reverse-transcriptase inhibitors alter expression of both mitochondrial and lipid metabolism genes in the absence of depletion of mitochondrial DNA', Journal of Infectious Diseases, vol. 191, pp. 1686 - 1696, http://dx.doi.org/10.1086/429697

Ammaranond P; Zaunders J; Satchell C; Van Bockel DJ; Cooper DA; Kelleher AD, 2005, 'A new variant cytotoxic T lymphocyte escape mutation in HLA-B27-positive individuals infected with HIV type 1', AIDS Research and Human Retroviruses, vol. 21, pp. 395 - 397, http://dx.doi.org/10.1089/aid.2005.21.395

Zaunders J; Munier M; Kaufmann D; Ip S; Grey PA; Smith DE; Ramacciotti TP; Quan D; Finlayson RJ; Kaldor JM; Rosenberg E; Walker BD; Cooper DA; Kelleher AD, 2005, 'Early proliferation of CCR5(+) CD38(+++) antigen-specific CD4(+) Th1 effector cells during primary HIV-1 infection', Blood, vol. 106, pp. 1660 - 1667, http://dx.doi.org/10.1182/blood-2005-01-0206

Lim H; Sedwell R; Duarte NL; Cooper DA; Kelleher AD; Carr AD; Mallon PW, 2005, 'Nucleoside reverse transcriptase inhibitor effects on adipocyte mitochondrial DNA quantity and quality in vitro', Antiviral Therapy, vol. 10, pp. L41 - L42, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000235133100081&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Sedwell R; Mallon PW; Duarte NL; Zaunders J; Kelleher AD; Cooper DA; Carr AD, 2005, 'Impaired mitochondrial function induced by NRTIs is only detectable in the monocyte (CD14(+)) subset of human PBMC', Antiviral Therapy, vol. 10, pp. L44 - L45, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000235133100087&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Zaunders JJ; Dyer WB; Wang B; Munier ML; Miranda-Saksena M; Newton R; Moore J; Mackay CR; Cooper DA; Saksena NK; Kelleher AD, 2004, 'Identification of circulating antigen-specific CD4⁺ T lymphocytes with a CCR5⁺, cytotoxic phenotype in an HIV-1 long-term nonprogressor and in CMV infection', Blood, vol. 103, pp. 2238 - 2247, http://dx.doi.org/10.1182/blood-2003-08-2765

Pett SL; Kelleher A, 2004, 'Antiretroviral therapy-induced immune restoration in HIV infection: A double-edged sword?', Expert Review of Anti-Infective Therapy, vol. 2, pp. 335 - 339, http://dx.doi.org/10.1586/14787210.2.3.335

Zaunders J; Dyer W; Wang B; Munier M; Miranda-Saksena M; Newton R; Moore JJ; MacKay CR; Cooper DA; Saksena NK; Kelleher AD, 2004, 'Identification of circulating antigen-specific CD4+ T lymphocytes with a CCR5+, cytotoxic phenotype in an HIV-1 long-term non-progressor and in CMV infection', Blood, vol. 8, pp. 2765 - 2765

Furutsuki T; Hosoya N; Kawana-Tachikawa A; Tomizawa M; Odawara T; Goto M; Kitamura Y; Nakamura T; Kelleher AD; Cooper DA; Iwamoto A, 2004, 'Frequent transmission of Cytotoxic-T-Lymphocyte escape mutants of human immunodeficiency virus type 1 in the highly HLA-A24-positive Japanese population', Journal of Virology, vol. 78, pp. 8437 - 8445, http://dx.doi.org/10.1128/JVI.78.16.8437-8445.2004

Lomas M; Liauw WS; Packham D; Williams KM; Kelleher AD; Zaunders J; Ward RL, 2004, 'Phase I clinical trial of a human idiotypic p53 vaccine in patients with advanced malignancy', Annals of Oncology, vol. 15, pp. 324 - 329, http://dx.doi.org/10.1093/annonc/mdh053

Mallon PW; Unemori P; Sedwell R; Morey AL; Rafferty M; Williams KM; Chisholm DJ; Samaras K; Emery S; Kelleher AD; Cooper DA; Carr AD, 2004, 'In vivo nucleoside reverse transcriptase inhibitors alter expression of both mitochondrial and lipid metabolism genes independent to HIV infection', Antiviral Therapy, vol. 9, pp. L11 - L11, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000231616000044&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Mallon PW; Sedwell R; Unemori P; Rafferty M; Williams KM; Chisholm DJ; Samaras K; Emery S; Kelleher AD; Cooper DA; Carr AD, 2004, 'Changes in nuclear gene expression resulting from NRTI-induced inhibition of mitochondrial transcription reveal links between mitochondrial dysfunction and lipid metabolism', Antiviral Therapy, vol. 9, pp. L56 - L56, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000231616000125&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Mallon PW; Sedwell R; Unemori P; Merlin K; McGinley C; Ammaranond P; Peperias M; Rafferty M; Williams KM; Samaras K; Morey AL; Chisholm DJ; Kelleher AD; Cooper DA; Carr AD, 2004, 'Nucleoside reverse transcriptase inhibitors (NRTI) decrease adipocyte and monocyte mitochondrial (mt) messenger RNA transcription in the absence of changes in mtDNA or cell morphology', Antiviral Therapy, vol. 9, pp. L56 - L57, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000231616000126&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Pett SL; Kelleher AD, 2003, 'Cytokine therapies in HIV-1 infection: Present and future', Expert Review of Anti-Infective Therapy, vol. 1, pp. 83 - 96, http://dx.doi.org/10.1586/14787210.1.1.83

Pett SL; Kelleher AD, 2003, 'Cytokine therapies in HIV-1 infection: present and future', Expert Review of Anti-Infective Therapy, vol. 1, pp. 89 - 102

Wang B; Mikhail M; Dyer W; Zaunders J; Kelleher AD; Saksena N, 2003, 'First demonstration of a lack of viral sequence evolution in a nonprogressor, defining replication-incompetent HIV-1 infection', Virology, vol. 312, pp. 135 - 135, http://dx.doi.org/10.1016/S0042-6822(03)00159-4

Zaunders J; Moutouh-de Parseval L; Kitada S; Reed JC; Rought S; Genini D; Leoni L; Kelleher AD; Cooper DA; Smith DE; Grey PA; Estaquier J; Little S; Richman DD; Corbeil J, 2003, 'Polyclonal proliferation and apoptosis of CCR5+ T Lymphocytes during primary human immunodeficiency virus type 1 infection: regulation by interleukin (IL)-2, IL-15, and Bcl-2', Journal of Infectious Diseases, vol. 187, pp. 1735 - 1735, http://dx.doi.org/10.1086/375030

Murray JM; Kaufmann GR; Hodgkin PD; Lewin SR; Kelleher AD; Davenport MP; Zaunders JJ, 2003, 'Naive T cells maintained by thymic output in early ages but by proliferation without phenotypic change after age twenty', Immunology and Cell Biology, vol. 81, pp. 487 - 495, http://dx.doi.org/10.1046/j.1440-1711.2003.01191.x

Ammaranond P; Cunningham PH; Oelrichs RB; Suzuki K; Harris C; Leas L; Grulich AE; Cooper DA; Kelleher AD; Harris C, 2003, 'Rates of transmission of antiretroviral drug resistant strains of HIV-1', Journal of Clinical Virology, vol. 26, pp. 153 - 153, http://dx.doi.org/10.1016/S1386-6532(02)00114-2

Ammaranond P; Cunningham PH; Oelrichs RB; Suzuki K; Harris C; Leas L; Grulich AE; Cooper DA; Kelleher AD; Harris C, 2003, 'No increase in protease resistance and a decrease in reverse transcriptase resistance mutations in primary HIV-1 infection: 1992-2001', AIDS, vol. 17, pp. 264 - 267, http://dx.doi.org/10.1097/00002030-200301240-00020

Allen TM; Kelleher AD; Zaunders J; Walker BD, 2002, 'Supervised or structured treatment interruption (STI) and beyond...', Biofutur, pp. 52 - 58

Allen TM; Kelleher AD; Zaunders J; Walker BD, 2002, 'Structured treatment interruption and beyond', BIOFUTUR, pp. 52 - 58, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000180098300009&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Kelleher AD; Sewell AK; Price DA, 2002, 'Dyslipidemia due to retroviral protease inhibitors [2] (multiple letters)', Nature Medicine, vol. 8, pp. 308 - 309

Kelleher AD; Sewell WA; Price DM, 2002, 'Dyslipidemia due to retroviral protease inhibitors', Nature Medicine, vol. 8, pp. 308 - 308, http://dx.doi.org/10.1038/nm0402-308a

Wang B; Dyer W; Zaunders J; Mikhail M; Sullivan JS; Haddad DM; Williams LA; Harris G; Holt J; Cooper DA; Miranda-Saksena M; Boadle R; Kelleher AD; Saksena NK, 2002, 'Comprehensive analyses of a unique HIV-1-infected nonprogressor reveal a complex association of immunobiological mechanisms in the context of replication-incompetent infection', Virology, vol. 304, pp. 246 - 264, http://dx.doi.org/10.1006/viro.2002.1706

Allen TM; Kelleher AD; Zaunders J; Walker BD, 2002, 'STI and beyond: the prospects of boosting anti-HIV immune responses', Trends in Immunology, vol. 23, pp. 456 - 460, http://dx.doi.org/10.1016/S1471-4906(02)02297-4

Appay V; Zaunders J; Papagno L; Sutton J; Jaramillo AB; Waters A; Eastbrook P; Grey PA; Smith DE; Mcmichael AJ; Cooper DA; Rowland-Jones SL; Kelleher AD, 2002, 'Characterization of CD4(+) CTLs ex vivo', Journal of Immunology, vol. 168, pp. 5954 - 5958, http://dx.doi.org/10.4049/jimmunol.168.11.5954

Cunliffe S; Wyer JR; Sutton J; Lucas M; Harcourt G; Klenerman P; Mcmichael AJ; Kelleher AD, 2002, 'Optimization of peptide linker length in production of MHC Class II/peptide tetrameric complexes increases yield, stability and allows identification of antigen specific CD4+ T cells in PBMC', European Journal of Immunology, vol. 32, pp. 3366 - 3375, http://dx.doi.org/10.1002/1521-4141(200212)32:12<3366::AID-IMMU3366>3.0.CO;2-#

Kelleher AD; Booth JL; Sewell AK; Oxenius A; Cerundolo V; McMichael AJ; Phillips RE; Price DA, 2001, 'Effects of retroviral protease inhibitors on proteasome function and processing of HIV-derived MHC class I-restricted cytotoxic T lymphocyte epitopes', AIDS Research and Human Retroviruses, vol. 17, pp. 1063 - 1066, http://dx.doi.org/10.1089/088922201300343744

Kelleher AD; Long C; Holmes EC; Allen RL; Wilson J; Conlon C; Workman C; Shaunak S; Olson K; Goulder P; Brander C; Ogg G; Sullivan JS; Dyer W; Jones I; McMichael AJ; Rowland-Jones S; Phillips RE, 2001, 'Clustered mutations in HIV-1 gag are consistently required for escape from HLA-B27-restricted cytotoxic T lymphocyte responses', Journal of Experimental Medicine, vol. 193, pp. 375 - 385, http://dx.doi.org/10.1084/jem.193.3.375

Suzuki K; Cunningham P; Harris C; Leas L; Zaunders J; Cooper DA; Kaufmann GR; Pett SL; Kelleher A; Mukaide M; Imai M; Kondo M; Finlayson R, 2001, 'Novel deletion of HIV type 1 reverse transcriptase residue 69 conferring selective high-level resistance to nevirapine', AIDS Research and Human Retroviruses, vol. 17, pp. 1293 - 1296, http://dx.doi.org/10.1089/088922201750461366

Kaufmann GR; Zaunders J; Murray JM; Kelleher AD; Lewin S; Solomon A; Smith DE; Cooper DA, 2001, 'Relative significance of different pathways of immune reconstitution in HIV type 1 infection as estimated by mathematical modelling.', AIDS Research and Human Retroviruses, vol. 17, pp. 147 - 159, http://dx.doi.org/10.1089/08892220150217238

Kelleher AD; Rowland-Jones SL, 2000, 'Functions of tetramer-stained HIV-specific CD4⁺ and CD8⁺ T cells', Current Opinion in Immunology, vol. 12, pp. 370 - 374, http://dx.doi.org/10.1016/S0952-7915(00)00102-3

McMichael AJ; Ogg G; Wilson J; Callan M; Hambleton S; Appay V; Kelleher T; Rowland-Jones S, 2000, 'Memory CD8⁺ T cells in HIV infection', Philosophical Transactions of the Royal Society B: Biological Sciences, vol. 355, pp. 363 - 367, http://dx.doi.org/10.1098/rstb.2000.0575

Oxenius A; Price DA; Easterbrook PJ; O'Callaghan CA; Kelleher AD; Whelan JA; Sontag G; Sewell AK; Phillips RE, 2000, 'Early highly active antiretroviral therapy for acute HIV-1 infection preserves immune function of CD8⁺ and CD4⁺ T lymphocytes', Proceedings of the National Academy of Sciences of the United States of America, vol. 97, pp. 3382 - 3387, http://dx.doi.org/10.1073/pnas.97.7.3382

Sewell AK; Price DA; Oxenius A; Kelleher AD; Phillips RE, 2000, 'Cytotoxic T lymphocyte responses to human immunodeficiency virus: Control and escape', Stem Cells, vol. 18, pp. 230 - 244, http://dx.doi.org/10.1634/stemcells.18-4-230

Kaufmann GR; Zaunders J; Kelleher AD; Grey PA; Smith DE; Carr AD; Cooper DA, 2000, 'Rapid restoration of CD4 T cell subsets in subjects receiving antiretroviral therapy during primary HIV-1 infection', AIDS, vol. 14, pp. 2543 - 2551, http://dx.doi.org/10.1097/00002030-200012010-00003

Price DA; Oxenius A; Easterbrook PJ; O'Callaghan CA; Kelleher A; Whelan JA; Sontag G; Sewell AK; Phillips RE, 2000, 'Highly active antiretroviral therapy for primary HIV-1 infection preserves immune function of virus-specific T lymphocytes', Quarterly Journal of Medicine, vol. 93, pp. 769 - 769

McMichael AJ; Kelleher A, 1999, 'The arrival of HLA class II tetramers', Journal of Clinical Investigation, vol. 104, pp. 1669 - 1770, http://dx.doi.org/10.1172/jci8943

Zaunders J; Cunningham PH; Kelleher AD; Kaufmann GR; Jaramillo AB; Wright RH; Smith DE; Grey PA; Vizzard J; Carr AD; Cooper DA, 1999, 'Potent antiretroviral therapy of primary HIV-1 infection: partial normalisation of T lympho-cyte subsets and limited reduction of proviral DNA despite clearance of plasma viremia.', Journal of Infectious Diseases, vol. 180, pp. 320 - 329, http://dx.doi.org/10.1086/314880

Benson EM; Clarkson J; Law MG; Marshall ; Kelleher AD; Smith DE; Patou G; Stewart GA; Cooper DA; French FA, 1999, 'Therapeutic vaccination with p24-VLP and zidovudine augments HIV-specific CTL activity in asymptomatic HIV infected individuals.', AIDS Research and Human Retroviruses, vol. 15, pp. 105 - 113, http://dx.doi.org/10.1089/088922299311538

Kelleher AD; Sewell WA; Cooper DA, 1999, 'Effect of protease therapy on cytokine secretion by peripheral blood mononuclear cells (PBMC) from HIV-infected subjects', Clinical and Experimental Immunology, vol. 115, pp. 147 - 152, http://dx.doi.org/10.1046/j.1365-2249.1999.00761.x

Wilson JDK; Ogg GS; Allen RL; Goulder PJR; Kelleher A; Sewell AK; O'Callaghan CA; Rowland-Jones SL; Callan MFC; McMichael AJ, 1998, 'Oligoclonal expansions of CD8⁺ T cells in chronic HIV infection are antigen specific', Journal of Experimental Medicine, vol. 188, pp. 785 - 790, http://dx.doi.org/10.1084/jem.188.4.785

Kelleher AD; Roggensack M; Jaramillo AB; Smith DE; Walker AC; Gow I; Mcmurchie M; Harris JA; Patou G; Cooper DA; Duncombe CJ; Bloch M; Quan D; Beveridge A; Genn B; Pethebridge A; Todhunter L; Baker D; Mcfarlane R; Mindel A; Knox J; O Connor C; Mitchell JR; Meese P; Chenworth I; Anderson JS; Roth N, 1998, 'Safety and immunogenicity of a candidate therapeutic vaccine, p24 virus-like particle, combined with zidovudine, in asymptomatic subjects', AIDS, vol. 12, pp. 175 - 182, http://dx.doi.org/10.1097/00002030-199802000-00007

Murray JM; Kaufmann GR; Kelleher AD; Cooper DA, 1998, 'A model of primary HIV-1 infection', Mathematical Biosciences, vol. 154, pp. 57 - 85, http://dx.doi.org/10.1016/S0025-5564(98)10046-9

Kaufmann GR; Cunningham PH; Kelleher AD; Zaunders J; Carr AD; Vizzard J; Law MG; Cooper DA; Catchpole BR; Baker D; Beveridge A; Bloch M; Byrne J; Doong N; Duncombe CJ; Finlayson R; Genn W; Kidd J; Mcfarlane R; Mcmurchie M; Mcnulty A; Pethebridge A; Quan D; Robertson M, 1998, 'Patterns of viral dynamics during primary human immunodeficiency virus type 1 infection', Journal of Infectious Diseases, vol. 178, pp. 1812 - 1815, http://dx.doi.org/10.1086/314480

Kelleher AD; Roggensack M; Emery S; Carr AD; French MA; Cooper DA, 1998, 'Effects of IL-2 therapy in asymptomatic HIV-infected individuals on proliferative responses to mitogens, recall antigens and HIV-related antigens', Clinical and Experimental Immunology, vol. 113, pp. 85 - 91, http://dx.doi.org/10.1046/j.1365-2249.1998.00633.x

Carr A; Kelleher A, 1998, 'Can Antiretroviral Therapy 'treat' Opportunistic Infections in Patients with HIV Infection', HIV Advances in Research and Therapy, vol. 8

Kelleher AD; Al-Harthi L; Landay AL, 1997, 'Immunological effects of antiretroviral and immune therapies for HIV.', AIDS (London, England), vol. 11 Suppl A

Kelleher S; Emery S; Cunningham PH; Duncombe CJ; Carr AD; Golding H; Forde S; Hudson J; Roggensack M; Forrest BD; Cooper DA, 1997, 'Safety and immunogenicity of UBI HIV-1MN octameric V3 peptide vaccine administered by subcutaneous injection', AIDS Research and Human Retroviruses, vol. 13, pp. 29 - 32, http://dx.doi.org/10.1089/aid.1997.13.29

Kelleher A, 1997, 'Restoring Immune Function through Antiretroviral Therapy', Clinical Insight, pp. 1 - 1

Carr A; Cunningham P; Kelleher A, 1997, 'Diagnosis and treatment of primary HIV infection', J HIV Combination Therapy, pp. 49 - 56

Kelleher AD; Smith DE; Cooper DA; Walker A; Gow I; Patou G, 1996, 'Effect of therapeutic vaccination (p24-VLP) and AZT on immunological markers in early HIV disease', AIDS, vol. 10, pp. P137 - P137, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1996VU96300198&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Walker A; Fagan D; Gow I; Kelleher A, 1996, 'The association between CD38 expression on T cells and delayed type hypersensitivity (DTH) response including tuberculin reactivity in asymptomatic HIV seropositive individuals', AIDS, vol. 10, pp. P114 - P114, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1996VU96300177&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Kelleher AD; Orth D, 1996, 'Early HIV-induced immune deficiency', Medical Journal of Australia, vol. 164, pp. 107 - 108, http://dx.doi.org/10.5694/j.1326-5377.1996.tb101366.x

Stewart GJ; Irvine SS; Scott M; Kelleher AD; Marriott DJ; McKnight I; Pethebridge AM; Wodak A; Ziegler J, 1996, 'Managing HIV. Part 1: Principles. 1.2 Strategies of care in managing HIV.', The Medical journal of Australia, vol. 164, pp. 99 - 104, http://dx.doi.org/10.5694/j.1326-5377.1996.tb101364.x

Kelleher AD; Orth D, 1996, 'Managing HIV:early HIV induced immune deficiency', Medical Journal of Australia, vol. 164, pp. 107 - 108

Carr AD; Emery S; Kelleher AD; Law MG; Cooper DA, 1996, 'CD8+ lymphocyte responses to antiretroviral therapy of HIV infection', Journal of acquired immune deficiency syndrome and human retrovirology, vol. 13, pp. 320 - 326, http://dx.doi.org/10.1097/00042560-199612010-00004

Kelleher AD; Carr AD; Zaunders J; Cooper DA, 1996, 'Alterations in the immune response of HIV-infected subjects treated with an HIV specific protease inhibitor, ritonavir', Journal of Infectious Diseases, vol. 173, pp. 321 - 329, http://dx.doi.org/10.1093/infdis/173.2.321

Kelleher A, 1996, 'HIV progression and the Immune System: Can HIV Be Eradicated from an Infected Individual', International Medical Press

Kelleher AD; Brew BJ; Milliken ST, 1994, 'Intractable headache as the presenting complaint of AIDS-related lymphoma confined to bone', Journal of Acquired Immune Deficiency Syndromes, vol. 7, pp. 629 - 630

Quinn D; Pocock N; Freund J; Kelleher A; Penny R; Brew B, 1993, 'Radionuclide hepatobiliary scanning in patients with AIDS-related sclerosing cholangitis', Clinical Nuclear Medicine, vol. 18, pp. 417 - 422, http://dx.doi.org/10.1097/00003072-199305000-00010

Kelleher A; Penny R, 1992, 'Immunoglobulin Therapy: Present Status', Present Therapeutics, pp. 39 - 46

Madhavi V; Wines B; Emery S; Amin J; Kelleher A; Hogarth M; Stratov I; Kent S, 2016, '"HIV-1 controllers" - what's their secret?', in EUROPEAN JOURNAL OF IMMUNOLOGY, WILEY-BLACKWELL, AUSTRALIA, Melbourne, pp. 74 - 74, presented at International Congress of Immunology (ICI), AUSTRALIA, Melbourne, 21 August 2016 - 26 August 2016, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000383610400148&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Wines BD; Vanderven HA; Esparon S; Madhavi V; Center RJ; Kristensen AB; Gonelli CA; Poumbourios A; Parsons M; Emery S; Kelleher A; Purcell DFJ; Kent SJ; Hogarth PM, 2016, 'Fc gamma R ectodomain probes measure anti-viral IgG effector function', in EUROPEAN JOURNAL OF IMMUNOLOGY, WILEY-BLACKWELL, AUSTRALIA, Melbourne, pp. 1256 - 1257, presented at International Congress of Immunology (ICI), AUSTRALIA, Melbourne, 21 August 2016 - 26 August 2016, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000391563600040&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Nasr N; Alshehri AA; Wright TK; Shahid M; Heiner BM; Harman AN; Botting RA; Helbig K; Kelleher AD; Suzuki K; Beard M; Hertzog P; Cunningham AL, 2016, 'HIV induces interferon stimulated genes in two phases in macrophages while inhibiting interferon induction', in EUROPEAN JOURNAL OF IMMUNOLOGY, WILEY-BLACKWELL, AUSTRALIA, Melbourne, pp. 630 - 630, presented at International Congress of Immunology (ICI), AUSTRALIA, Melbourne, 21 August 2016 - 26 August 2016, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000383610401456&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Worley M; Kelleher AD; Kent SJ; Chung AW, 2016, 'Neutrophils mediate potent and rapid anti-HIV antibody-dependent functions', in EUROPEAN JOURNAL OF IMMUNOLOGY, WILEY-BLACKWELL, AUSTRALIA, Melbourne, pp. 73 - 74, presented at International Congress of Immunology (ICI), AUSTRALIA, Melbourne, 21 August 2016 - 26 August 2016, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000383610400147&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Worley MJ; Kelleher AD; Kent SJ; Chung AW, 2016, 'Neutrophils mediate potent and rapid anti-HIV antibody-dependent functions', in JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, JOHN WILEY & SONS LTD, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000395394300142&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Pham QD; Wilson DP; Law M; Kelleher A; Zhang L, 2014, 'Transmission modes of HIV and risk of infection of antiretroviral resistance among treatment-naive HIV-infected people: a global systematic review and meta-analysis', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, GERMANY, Berlin, pp. A65 - A65, presented at International Workshop on Antiviral Drug Resistance - Meeting the Global Challenge, GERMANY, Berlin, 03 June 2014 - 07 June 2014, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000354380300059&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Achhra AC; Boyd M; Law MG; Matthews G; Kelleher AD; Cooper DA, 2013, 'Sequencing antiretroviral therapy to maximize patient safety: could we move away from ritonavir, abacavir, tenofovir and efavirenz (RATE) - agents that concern prescribers and patients? A feasibility study and call for a trial', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, BELGIUM, Brussels, pp. A51 - A51, presented at 15th International Workshop on Co-morbidities and Adverse Drug Reaction in HIV, BELGIUM, Brussels, 15 October 2013 - 17 October 2013, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000335230200056&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Kramski M; Madhavi V; Jegaskanda S; Center RJ; Batiz FEAS; Ananworanich J; Cooper D; Kelleher A; Hsu D; Kent SJ, 2013, 'Decreased HIV-Specific Antibody-Dependent Cellular Cytotoxicity in HIV-Infected Subjects on cART: Implications for Therapeutic Vaccines', in AIDS RESEARCH AND HUMAN RETROVIRUSES, MARY ANN LIEBERT, INC, SPAIN, Barcelona, pp. A52 - A53, presented at Conference on AIDS Vaccine, SPAIN, Barcelona, 07 October 2013 - 10 October 2013, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000326037500128&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Kuang X; Le A; Mwimanzi P; Anmole G; Ueno T; Miura T; Connick E; Daar ES; Kelleher A; Jessen H; Little S; Markowitz M; Pereyra F; Rosenberg E; Walker B; Brumme Z; Brockman M, 2013, 'Impaired Early HIV-1 Nef Function in Spontaneous Viremic Controllers', in AIDS RESEARCH AND HUMAN RETROVIRUSES, MARY ANN LIEBERT, INC, SPAIN, Barcelona, pp. A83 - A84, presented at Conference on AIDS Vaccine, SPAIN, Barcelona, 07 October 2013 - 10 October 2013, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000326037500210&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Namasivayam M; Zaunders J; Ip S; Scott G; Shaw PJ; Trahair T; O'Brien T; Rawlinson W; Walls T; Kelleher A; Ziegler JB, 2013, 'QUANTIFICATION OF HUMAN CYTOMEGALOVIRUS-SPECIFIC T-CELL RESPONSES IN PAEDIATRIC PATIENTS FOLLOWING HAEMATOPOIETIC STEM CELL TRANSPLANTATION', in INTERNAL MEDICINE JOURNAL, WILEY-BLACKWELL, pp. 13 - 13, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000323685200040&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Land S; Tu E; Swenson L; Kelleher A; Kaye S; Pett SL; Emery S; Kaiser R; Silk D; Berthon-Jones N; Harrigan PR, 2013, 'Proviral DNA testing of HIV tropism in the Maraviroc Switch Collaborative Study (MARCH) - results of a three-phase quality assurance (QA) programme', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, CANADA, Toronto, pp. A144 - A144, presented at International Workshop on HIV and Hepatitis Virus Drug Resistance and Curative Strategies, CANADA, Toronto, 04 June 2013 - 08 June 2013, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000335229500117&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Suzuki K; Swaminathan S; Hood C; Cooper DA; Watanebe T; Kelleher AD, 2011, 'SEQUENCE SPECIFIC INDUCTION OF HIV-1 TRANSCRIPTIONAL GENE SILENCING TARGETING NF-kappa B SEQUENCES BY SIRNA WITHOUT ANY OFF-TARGET EFFECTS OF OTHER NF-kappa B DRIVEN GENES', in JOURNAL OF GENE MEDICINE, WILEY-BLACKWELL, AUSTRALIA, Univ Melbourne, Bio21 Inst, Parkville, pp. 425 - 425, presented at 7th Biennial Meeting of the Australasian-Gene-Therapy-Society, AUSTRALIA, Univ Melbourne, Bio21 Inst, Parkville, 04 May 2011 - 06 May 2011, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000297950900031&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Namasivayam M; Zaunders J; Ip S; Scott GM; Shaw P; Trahair TN; O''brien T; Rawlinson WD; Walls T; Kelleher AD; Ziegler JB, 2011, 'Performance of quantiferon-cmv (r) and whole-blood cd4(+)cd25(+)cd134(+) assays in identification of human cytomegalovirus-specific t-cells in children post-haematopoietic stem cell transplantation', in Internal Medicine Journal, Blackwell Publishing Asia, pp. 12 - 12, http://dx.doi.org/10.1111/%28ISSN%291445-5994

Munier CM; Bailey MR; Xu Y; Liu S; Cooper DA; Zaunders J; Kent SJ; Kelleher AD, 2011, 'Primary Immune Responses to Vaccinia Virus Vaccination: The Role of Cytotoxic Effector CD4+ T Cells in the Generation of Human T Cell Memory', in AIDS Research and Human Retroviruses, Mary Ann Liebert Inc, Bangkok, THAILAND, pp. A129 - A139, presented at Conference on AIDS Vaccine, Bangkok, THAILAND, 12 September 2011 - 15 September 2011, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000295790500334&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Koelsch KK; Xu Y; Bailey M; McBride K; Seddiki N; Suzuki K; Murray J; Cooper DA; Kelleher AD; Zaunders J, 2010, 'Most HIV DNA in PBMC is present in non-gut-homing, resting central memory CD4 T-cells', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, Dubrovnik, CROATIA, pp. A44 - A44, presented at International HIV and Hepatitis Virus Drug Resistance and Curative Strategies Workshop, Dubrovnik, CROATIA, 08 June 2010 - 12 June 2010, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000287431300040&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Koelsch KK; Xu Y; Bailey M; McBride K; Seddiki N; Suzuki K; Murray J; Cooper DA; Kelleher AD; Zaunders J, 2010, 'Most HIV DNA in PBMC is present in non-gut-homing, resting central memory CD4 T-cells.', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, Dubrovnik, CROATIA, pp. A44 - A44, presented at International HIV and Hepatitis Virus Drug Resistance and Curative Strategies Workshop, Dubrovnik, CROATIA, 08 June 2010 - 12 June 2010, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000280215800055&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Distler O; Mallon PW; Kelleher AD; Carr A; Calmy A; Cooper DA, 2009, 'Evaluation of adipose gene expression and mitochondrial DNA in healthy adults over a 6 week course of NRTI and/or PI treatment. Indications of divergent effects', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, PA, Philadelphia, pp. A10 - A11, presented at 11th International Workshop on AdverseDrug Reactions and Co-Morbidities in HIV, PA, Philadelphia, 26 October 2009 - 28 October 2009, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000272060000029&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Matthews PC; Leslie A; Katzourakis A; Power K; Kelleher AD; Allen T; Pybus OG; Goulder PJ, 2008, 'HLA Footprints in HIV-1 Drive Phylogenetic Clustering and Inter-Clade Variation', in AIDS RESEARCH AND HUMAN RETROVIRUSES, MARY ANN LIEBERT INC, SOUTH AFRICA, Cape Town, pp. 75 - 75, presented at AIDS Vaccine 2008 Conference, SOUTH AFRICA, Cape Town, 13 October 2008 - 16 October 2008, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000260530800187&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Buchbinder SP; Mehrotra DV; Duerr A; Fitzgerald DW; Mogg R; Li D; Gilbert PB; Lama JR; Marmor M; del Rio C; McElrath MJ; Casimiro DR; Gottesdiener KM; Chodakewitz JA; Corey L; Robertson MN, 2008, 'Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial', in The Lancet, pp. 1881 - 1893, http://dx.doi.org/10.1016/S0140-6736(08)61591-3

Streeck H; Jolin J; Yassine-Diab B; Qi YC; Kwon D; Addo M; Brumme C; Routy J; Little SE; Jessen H; Kelleher AD; Sekaly R; Rosenberg E; Walker BD; Carrington M; Altfeld M, 2008, 'Early CD8+T Cell Responses are the Major Contributors to the Later Viral Set Point', in AIDS Research and Human Retroviruses, Mary Ann Liebert Inc, Larchmont, NY, USA, pp. 7 - 7, presented at AIDS Research and Human Retroviruses, Cape Town, SOUTH AFRICA, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000260530800014&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Brumme C; Brumme Z; Carlson J; Markowitz M; Jessen H; Kelleher AD; John M; Mallal SS; Allen T; Heckerman D; Walker BD, 2008, 'Reversion of HLA-Associated Polymorphisms in Gag, Pol and Nef during the First Year of HIV Infection: Sites, Rates and pVL Correlations', in AIDS Research and Human Retroviruses, Mary Ann Liebert Inc, Larchmont, NY, USA, pp. 76 - 77, presented at AIDS Research and Human Retroviruses, Cape Town, SOUTH AFRICA, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000260530800190&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Schneidewind A; Brumme Z; Brume C; Power KA; Reyor L; O Sullivan K; Jessen H; Markowitz M; Rosenberg E; Sekaly R; Kelleher AD; Walker BD; Allen TM, 2008, 'Long-term Stability of Compensated CTL Escape Mutations following Acute HIV Infection', in AIDS Research and Human Retroviruses, Mary Ann Liebert Inc, Larchmont, NY, USA, pp. 78 - 78, presented at AIDS Research and Human Retroviruses, Cape Town, SOUTH AFRICA, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000260530800195&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Zaunders J; Dyer W; Munier CM; Ip S; Rawlinson WD; Sullivan JS; Cooper DA; Kelleher AD, 2006, 'Transient CCR5+ CD38+++ CD4+ effector TH1 cells are an early component of the primary immune response to vaccinia and immediately precede IL-2+ memory CD4+ T cells', in CYTOMETRY PART A, Wiley-Liss, Queensland, AUSTRIA, pp. 400 - 400, presented at 7th Samuel A Latt Conference on Stem Cells in the Age of Fluorescence Technology, Queensland, AUSTRIA, 06 November 2005 - 09 November 2005, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000237187700019&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Fazekas de St Groth B; Seddiki N; Tan S; Higgins C; Power C; Santner-Nanan B; Nanan R; Sasson S; Zaunders J; Kelleher A; Landay A, 2005, 'Regulatory T cells and the maintenance of tolerance', in TISSUE ANTIGENS, BLACKWELL PUBLISHING, AUSTRALIA, Melbourne, pp. 412 - 412, presented at 35th Annual SCientific Meeting of the Australasian-Society-for-Immunology/14th International HLA and Immunogenetics Workshops, AUSTRALIA, Melbourne, 29 November 2005 - 02 December 2005, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000233542700194&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Ip S; Zaunders JJ; Munier M; Cooper DA; Kelleher AD, 2005, 'Optimizing 9-colour analysis of gut-homing CD4+T cell subsets', in CYTOMETRY PART A, WILEY-LISS, AUSTRIA, Queensland, pp. 400 - 400, presented at 7th Samuel A Latt Conference on Stem Cells in the Age of Fluorescence Technology, AUSTRIA, Queensland, 06 November 2005 - 09 November 2005, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000237187700020&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Van Bockel DJ; Suzuki K; Warton K; Ammaranond P; Douek D; La Gruta N; Munier M; McGinley C; Nallaiah K; Stanley K; Turner SJ; Zaunders J; Cooper DA; Kelleher AD, 2005, 'TCR clonotypic analysis of CMV antigen-specific CD8+ T-cells from formaldehyde fixed peripheral blood', in Tissue Antigens, Blackwell Munksgaard, Melbourne, AUSTRALIA, pp. 573 - 574, presented at 35th Annual SCientific Meeting of the Australasian-Society-for-Immunology/14th International HLA and Immunogenetics Workshops, Melbourne, AUSTRALIA, 29 November 2005 - 02 December 2005, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000233542700629&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Munier M; Zaunders J; Ip S; Cooper DA; Kelleher AD, 2005, 'Development and optimisation of a culture amplified multiparametric intraceilular cytokine assay for the assessment of vaccine immunogenicity', in Tissue Antigens, Blackwell Munksgaard, Melbourne, AUSTRALIA, pp. 499 - 499, presented at 35th Annual SCientific Meeting of the Australasian-Society-for-Immunology/14th International HLA and Immunogenetics Workshops, Melbourne, AUSTRALIA, 29 November 2005 - 02 December 2005, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000233542700430&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Puls R; Munier M; MCgHIE K; Chadborn I; Emery S; Kelleher AD; Law MG; Carr AD, 2003, 'HIV Lipodystrophy Case Definition Study Group. Impact of adiponectin, C-reactive protein and leptin on the HIV lipodystrophy case definition', in Antiviral Therapy, Int Medical Press Ltd, pp. 57 - 57

Puls R; Munier M; MCgHIE K; Chadborn I; Emery S; Kelleher AD; Law MG; Carr AD, 2003, 'Impact of adiponectin, C-reactive protein and leptin on the HIV lipodystrophy case definition', in Antiviral Therapy, Int Medical Press Ltd, Paris, FRANCE, pp. L73 - L73, presented at 5th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV, Paris, FRANCE, 08 July 2003 - 11 July 2003, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000231266500130&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Mallon PWG; Munier ML; McGhie K; Zaunders J; Kelleher A; Cooper DA; Carr A, 2002, 'Disrupted expression of lipid transport genes in monocytes of individuals with HIV-associated lipodystrophy - an additional risk for cardiovascular disease?', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, CALIFORNIA, SAN DIEGO, pp. L8 - L9, presented at 4th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV, CALIFORNIA, SAN DIEGO, 22 September 2002 - 25 September 2002, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000179501500023&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Kelleher AD; Zaunders J; Cunningham P; Kauffmann G; Carr A; Smith D; Cooper DA, 1998, 'Restoration of immunity with antiretroviral therapy', in AIDS, LIPPINCOTT WILLIAMS & WILKINS, pp. S3 - S3, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000077311300010&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Clarkson J; French FA; Law MG; Marshall ; Kelleher AD; Smith DE; Patou G; Cooper DA; Stewart GA; Benson EM, 1997, 'Therapeutic vaccination with p24-VLP and AZT augments HIV specific CTL activity in asymptomatic HIV-infected individuals.', in Australasian Society for HIV Medicine 9th Annual Conference, Australasian Society for HIV Medicine 9th Annual Conference, Adelaide, Sth Aust, presented at Australasian Society for HIV Medicine 9th Annual Conference, Adelaide, Sth Aust, 13 November 1997 - 16 November 1997

Bloch M; Kelleher AD; Smith DE; Grey PA; Zaunders J; Cooper DA, 1997, 'CD8 activation does not totally normalise in treated primary HIV infection despite undetectable viral load; evidence for ongoing viral replication?', in 6th European Conference on Clinical Aspects and Treatment of HIV-Infection, 6th European Conference on Clinical Aspects and Treatment of HIV-Infection, Hamburg, Germany, presented at 6th European Conference on Clinical Aspects and Treatment of HIV-Infection, Hamburg, Germany, 11 October 1997 - 15 October 1997

Kelleher AD; Bloch M; Smith DE; Grey PA; Cunningham PH; Zaunders J; Cooper DA, 1997, 'Reversal of CD8 activation in patients with primary HIV infection treated with AZT, 3TC and indinavir.', in 37th Interscience Conference on Antimicrobial Agents and Chemotherapy, 37th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Ontario, Canada, presented at 37th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Ontario, Canada, 29 September 1997 - 01 October 1997

Smith DE; Bloch M; Grey PA; Cunningham PH; Zaunders J; Kelleher AD; Cooper DA, 1997, 'Reversal of lymphocyte RA/RO ratios in patients with primary HIV infection treated with zidovudine, lamivudine and indinavir.', in International Workshop on HIV Drug Resistance, Treatment Strategies and Eradication, International Workshop on HIV Drug Resistance, Treatment Strategies and Eradication, St Petersburg, Florida, USA, presented at International Workshop on HIV Drug Resistance, Treatment Strategies and Eradication, St Petersburg, Florida, USA, 25 June 1997 - 29 June 1997

Kelleher AD; Walker AC; Jaramillo AB; Roggensack M; Smith DE; Gow I; Cooper DA, 1997, 'Effect of therapeutic vaccine p24-VLP and AZT on immunological and virological markets in asymptomatic subjects', in 4th Conference on Retrovirology and Opportunistic Infections, 4th Conference on Retroviruses and Opportunistic Infections, Washington DC, USA, presented at 4th Conference on Retrovirology and Opportunistic Infections, Washington DC, USA

Kelleher AD; Cooper DA, 1996, 'Can antiviral therapy restore immune function?', in AIDS, RAPID SCIENCE PUBLISHERS, pp. 23 - 23, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1996VU96300005&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Kelleher AD; Smith DE; Cooper DA; Walker AC; Gow I; Patou G, 1996, 'Effects of therapeutic vaccination (p24-VLP) and AZT on immunological and virological markers in asymptomatic subjects', in 3rd International Congress on Drug Therapy in HIV Infection, 3rd International Congress on Drug Therapy in HIV Infection, Birmingham, England, pp. 137 - 137, presented at 3rd International Congress on Drug Therapy in HIV Infection, Birmingham, England

JACOBS NH; WHYTE S; KELLEHER AD; JUAREZ CC; GARRICK R; FENELEY MP, 1990, 'LIMITED ROLE OF TRANSESOPHAGEAL ECHOCARDIOGRAPHY IN UNSELECTED PATIENTS WITH CEREBRAL ISCHEMIC EVENTS', in CIRCULATION, AMER HEART ASSOC, pp. 110 - 110, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1990EC76400454&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Wong A; Aggarwal A; Atthi O; Hao B; Macrae H; Churchill M; Kelleher A; Turville S, 2018, 'Modular gene therapy vectors for gene therapy cure in resting immune cells', in JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, JOHN WILEY & SONS LTD, Vol. 21, pp. 4 - 4, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000440002700009&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Bavinton B; Grinsztejn B; Phanuphak N; Jin F; Zablotska I; Prestage G; Kelleher A; Pinto A; Cooper D; Grulich A, 2017, 'HIV treatment prevents HIV transmission in male serodiscordant couples in Australia, Thailand and Brazil', in JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, JOHN WILEY & SONS LTD, Vol. 20, pp. 115 - 115, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000406429800213&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Munier CML; Bailey M; Ip S; Xu Y; Alcantara S; Liu SM; van Bockel D; Suzuki K; Cooper DA; Kent SJ; Zaunders JJ; Kelleher AD, 2016, 'The primary immune response to vaccinia virus vaccination includes cells with a distinct cytotoxic effector CD4 T cell phenotype', in EUROPEAN JOURNAL OF IMMUNOLOGY, WILEY-BLACKWELL, AUSTRALIA, Melbourne, Vol. 46, pp. 676 - 677, presented at International Congress of Immunology (ICI), AUSTRALIA, Melbourne, 21 August 2016 - 26 August 2016, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000383610401550&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Xu Y; Bailey M; Phetsouphanh C; Harvey R; Turville S; Aggarwal A; Wong A; Suzuki K; Graff-Dubois S; Autran B; Moris A; Munier ML; Koelsch K; Kent S; Zaunders J; Kelleher A, 2016, 'Accumulation of follicular T Helper (Tfh) cells, despite preferential infection, allows establishment of a large and unexpected viral reservoir during HIV infection', in EUROPEAN JOURNAL OF IMMUNOLOGY, WILEY-BLACKWELL, AUSTRALIA, Melbourne, Vol. 46, pp. 264 - 264, presented at International Congress of Immunology (ICI), AUSTRALIA, Melbourne, 21 August 2016 - 26 August 2016, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000383610400533&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Tong WWY; Turville S; Roberts J; Zaunders J; Jin F; Poynten IM; Hillman R; Grulich A; Kelleher A; Carr A, 2016, 'T-cells in the anal mucosa of men with high- grade squamous intraepithelial lesions', in EUROPEAN JOURNAL OF IMMUNOLOGY, WILEY-BLACKWELL, AUSTRALIA, Melbourne, Vol. 46, pp. 240 - 240, presented at International Congress of Immunology (ICI), AUSTRALIA, Melbourne, 21 August 2016 - 26 August 2016, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000383610400486&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Sasson SC; McGill K; Weinholt L; Carr A; Brown DA; Kelleher AD; Breit SN; Sewell WA, 2015, 'COMPARISON OF THE FREELITE (TM) SERUM FREE LIGHT CHAIN (SFLC) ASSAY WITH SERUM AND URINE ELECTROPHORESIS/IMMUNOFIXATION AND THE N LATEX FLC ASSAY', in INTERNAL MEDICINE JOURNAL, WILEY-BLACKWELL, Vol. 45, pp. 24 - 24, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000360834700077&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Tong WWY; Turville S; Roberts J; Zaunders J; Jin F; Poynten IM; Hillman RJ; Grulich AE; Kelleher AD; Carr A, 2015, 'T-CELLS IN THE ANAL MUCOSA OF MEN WITH HIGH-GRADE SQUAMOUS INTRAEPITHELIAL LESIONS', in SEXUALLY TRANSMITTED INFECTIONS, BMJ PUBLISHING GROUP, Vol. 91, pp. A168 - A168, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000416106400440&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Danta M; Zaunders J; Bailey MR; Marks K; Seddiki N; Emery S; Murray JM; Cooper DA; Koelsch K; Kelleher AD, 2012, 'Primary HIV-1 infection (PHI) is associated with reduced CD4 cell counts in terminal ileum biopsies, but not other gut biopsy sites', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL, Vol. 27, pp. 19 - 19, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000308642600039&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Aggarwal A; Stella AO; Walker G; Akerman A; Milogiannakis V; Brilot F; Amatayakul-Chantler S; Roth N; Coppola G; Schofield P; Jackson J; Henry J; Mazigi O; Langley D; Lu Y; Forster C; McAllery S; Mathivanan V; Fichter C; Hoppe AC; Munier ML; Jack H-M; Cromer D; Darley D; Matthews G; Christ D; Khoury D; Davenport M; Rawlinson W; Kelleher A; Turville S, 2021, SARS-CoV-2 Omicron: evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern, http://dx.doi.org/10.1101/2021.12.14.21267772

Counoupas C; Johansen M; Stella A; Nguyen D; Ferguson A; Aggarwal A; Bhattacharyya N; Grey A; Patel K; Siddiquee R; Stewart E; Feng C; Hansbro N; Palendira U; Steain M; Saunders B; Low J; Mackay J; Kelleher A; Britton W; Turville S; Hansbro P; Triccas J, 2020, A single dose, BCG-adjuvanted COVID-19 vaccine provides sterilizing immunity against SARS-CoV-2 infection in mice, http://dx.doi.org/10.1101/2020.12.10.419044

Aggarwal A; Akerman A; Milogiannakis V; Silva MR; Walker G; Kidinger A; Angelovich T; Waring E; Amatayakul-Chantler S; Roth N; Yeang M; Jean T; Foster C; Hoppe AC; Munier ML; Darley DR; Churchill M; Starck D; Christ D; Matthews G; Rawlinson W; Kelleher A; Turville S, SARS-CoV-2 Omicron BA.5: Evolving Tropism and Evasion of Potent Humoral Responses and Resistance to Clinical Immunotherapeutics Relative to Viral Variants of Concern, http://dx.doi.org/10.2139/ssrn.4157473